A measuring device of the present disclosure includes a measurement part that measures a target substance contained in a sample solution, a tool placement area on which a tool used for the measurement is placed and that is disposed above the measurement part in a vertical direction, a dispensing part that dispenses a liquid and is movable above the tool placement area, and a housing that accommodates the measurement part, the tool placement area, and the dispensing part therein.
G01N 35/10 - Dispositifs pour transférer les échantillons vers, dans ou à partir de l'appareil d'analyse, p. ex. dispositifs d'aspiration, dispositifs d'injection
G01N 33/579 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir un lysat de limulus
G01N 35/00 - Analyse automatique non limitée à des procédés ou à des matériaux spécifiés dans un seul des groupes Manipulation de matériaux à cet effet
Provided are: a washing method for a flow-type reaction system comprising cleaning the inside of a flow channel of a flow-type reaction system using a solution of an organic acid compound having a pKa of 0.50 or less; and a detergent for a flow-type reaction system containing an organic acid compound having a pKa of 0.50 or less as an active ingredient.
Provided are a polycarbonate resin containing structural units (A) to (C) represented by Formulae (A) to (C), in which a proportion of (A): (B): (C) is 25 to 45 mol %:25 to 45 mol %:15 to 50 mol %; and a molded product containing the same.
Provided are a polycarbonate resin containing structural units (A) to (C) represented by Formulae (A) to (C), in which a proportion of (A): (B): (C) is 25 to 45 mol %:25 to 45 mol %:15 to 50 mol %; and a molded product containing the same.
Provided are a polycarbonate resin containing structural units (A) to (C) represented by Formulae (A) to (C), in which a proportion of (A): (B): (C) is 25 to 45 mol %:25 to 45 mol %:15 to 50 mol %; and a molded product containing the same.
In the formulae, R1 represents a C6 or more aliphatic hydrocarbon group and R2 represents a hydrogen atom or a substituent. R3 represents a substituent. n is an integer of 0 to 8 and m is an integer of 4+n or less. R4 represents a hydrogen atom or a C1 to C5 aliphatic hydrocarbon group. Here, R1 and R2, or R4's are not bonded to each other to form a ring. * represents a bonding site.
Provided are a polycarbonate resin containing structural units (A) to (C) represented by Formulae (A) to (C), in which a proportion of (A): (B): (C) is 25 to 45 mol %:25 to 45 mol %:15 to 50 mol %; and a molded product containing the same.
In the formulae, R1 represents a C6 or more aliphatic hydrocarbon group and R2 represents a hydrogen atom or a substituent. R3 represents a substituent. n is an integer of 0 to 8 and m is an integer of 4+n or less. R4 represents a hydrogen atom or a C1 to C5 aliphatic hydrocarbon group. Here, R1 and R2, or R4's are not bonded to each other to form a ring. * represents a bonding site.
A 1,4-phenylene group in the formulae may be substituted with an aliphatic hydrocarbon group and/or an aromatic hydrocarbon group.
C08G 64/06 - Polycarbonates aromatiques ne contenant pas d'insaturations aliphatiques
B29C 45/00 - Moulage par injection, c.-à-d. en forçant un volume déterminé de matière à mouler par une buse d'injection dans un moule ferméAppareils à cet effet
B29K 69/00 - Utilisation de polycarbonates comme matière de moulage
Provided is a biaryl compound production method including: producing a benzyne compound from a precursor of a benzyne compound; subjecting the benzyne compound and a furan compound to a Diels-Alder reaction to produce a condensed ring compound containing a 1,4-epoxy-1,4-dihydrobenzene ring; and subjecting the condensed ring compound and a halogenated aryl compound to a cross-coupling reaction to produce a biaryl compound.
C07C 1/26 - Préparation d'hydrocarbures à partir d'un ou plusieurs composés, aucun d'eux n'étant un hydrocarbure à partir de composés organiques ne renfermant que des atomes d'halogènes en tant qu'hétéro-atomes
C07C 15/56 - Hydrocarbures cycliques ne contenant que des cycles aromatiques à six chaînons en tant que partie cyclique substitués par des radicaux hydrocarbonés non saturés polycycliques condensés
C07C 41/30 - Préparation d'éthers par des réactions ne formant pas de liaisons sur l'oxygène de la fonction éther par augmentation du nombre d'atomes de carbone, p. ex. par oligomérisation
C07C 43/205 - Éthers une liaison sur l'oxygène de la fonction éther étant sur un atome de carbone d'un cycle aromatique à six chaînons le cycle aromatique n'étant pas condensé
C07C 45/70 - Préparation de composés comportant des groupes C=O liés uniquement à des atomes de carbone ou d'hydrogènePréparation des chélates de ces composés par des réactions ne créant pas de groupe C=O par isomérisationPréparation de composés comportant des groupes C=O liés uniquement à des atomes de carbone ou d'hydrogènePréparation des chélates de ces composés par des réactions ne créant pas de groupe C=O par modification de la taille du squelette carboné par augmentation du nombre d'atomes de carbone par réaction de groupes fonctionnels contenant de l'oxygène lié uniquement par liaison simple
C07C 49/83 - Cétones comportant un groupe cétone lié à un cycle aromatique à six chaînons contenant des groupes hydroxyle polycycliques
C07C 67/343 - Préparation d'esters d'acides carboxyliques par modification de la partie acide de l'ester sans introduction d'un groupe ester par isomérisationPréparation d'esters d'acides carboxyliques par modification de la partie acide de l'ester sans introduction d'un groupe ester par modification de la taille du squelette carboné par augmentation du nombre d'atomes de carbone
C07C 69/76 - Esters d'acides carboxyliques dont un groupe carboxyle estérifié est lié à un atome de carbone d'un cycle aromatique à six chaînons
COMPOSITE NEGATIVE ELECTRODE ACTIVE MATERIAL, SLURRY FOR SECONDARY BATTERY NEGATIVE ELECTRODE, NEGATIVE ELECTRODE SHEET AND SECONDARY BATTERY, AND METHOD FOR MANUFACTURING NEGATIVE ELECTRODE SHEET AND SECONDARY BATTERY
Provided are a composite negative electrode active material, a slurry for a secondary battery negative electrode, a negative electrode sheet, a secondary battery, and a method for manufacturing a negative electrode sheet and a secondary battery, the composite negative electrode active material having a negative electrode active material, and a coating layer that covers the surface of the negative electrode active material and contains a polymer containing a constituent component represented by general formula (A-1), the coating layer content of the composite negative electrode active material being greater than 5.0 mass%. In the formula, R11to R13each denote a hydrogen atom or a C1-6 alkyl group, and R14and R15 each denote a hydrogen atom, a C1-16 alkyl group, or a C6-12 aryl group. * indicates a bonding site to be incorporated into the main chain of the polymer.
H01M 4/48 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques
C08L 25/02 - Homopolymères ou copolymères d'hydrocarbures
C08L 33/24 - Homopolymères ou copolymères des amides ou des imides
H01M 4/36 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs
H01M 4/38 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'éléments simples ou d'alliages
6.
COMPOSITE NEGATIVE ELECTRODE ACTIVE MATERIAL, COMPOSITION FOR SECONDARY BATTERY NEGATIVE ELECTRODES, NEGATIVE ELECTRODE SHEET AND SECONDARY BATTERY, AND METHODS FOR MANUFACTURING NEGATIVE ELECTRODE SHEET AND SECONDARY BATTERY
Provided are: a composite negative electrode active material which has a negative electrode active material and a coating layer that covers the surface of the negative electrode active material and is composed of a polymer containing constituent components of general formula (A-1) and/or (A-2), wherein the content of the coating layer in the composite negative electrode active material is 0.05-5% by mass; a composition for secondary battery negative electrodes; a negative electrode sheet and a secondary battery; and methods for manufacturing a negative electrode sheet and a secondary battery. In the formulae, R11to R13and R21to R23each represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, R14and R15 each represent a hydrogen atom, an alkyl group having 1 to 16 carbon atoms, or an aryl group having 6 to 12 carbon atoms, and * indicates the binding site to be incorporated into the main chain of the polymer.
This method for producing a compound represented by formula (2) comprises bringing at least one acid catalyst, which is selected from organic Brønsted acids and activated clay that is activated by a Brønsted acid, into contact with a compound represented by formula (1) at a temperature equal to or higher than 70°C. In formula (1) and formula (2), X represents an oxygen atom, -NH-, or a sulfur atom, Z represents CH or a nitrogen atom, R1represents an aprotic substituent, R2 represents a substituent, and n represents an integer of 0-3. However, among the two carbon atoms adjacent to the carbon atom substituted with X in the aromatic ring in formula (1), at least the carbon atom bound to Z and to the carbon atom substituted with X has a hydrogen atom. The aromatic ring in each of the formulae may be fused with another ring to form a fused ring.
C07C 45/54 - Préparation de composés comportant des groupes C=O liés uniquement à des atomes de carbone ou d'hydrogènePréparation des chélates de ces composés par pyrolyse, réarrangement ou décomposition de composés contenant des atomes d'oxygène liés par des liaisons doubles, p. ex. d'esters
B01J 31/02 - Catalyseurs contenant des hydrures, des complexes de coordination ou des composés organiques contenant des composés organiques ou des hydrures métalliques
C07C 49/825 - Cétones comportant un groupe cétone lié à un cycle aromatique à six chaînons contenant des groupes hydroxyle tous les groupes hydroxyle étant liés au cycle
C07C 49/83 - Cétones comportant un groupe cétone lié à un cycle aromatique à six chaînons contenant des groupes hydroxyle polycycliques
Disclosed is a method for producing an electrophilic substituted aromatic compound, the method including continuously performing, by a flow reaction, a reaction in which a metallized aromatic compound is produced by reacting a halogenated aromatic compound with an organometallic compound, and subsequently the metallized aromatic compound is reacted with an electrophilic compound so as to produce an electrophilic substituted aromatic compound. This method for producing an electrophilic substituted aromatic compound includes flowing a liquid that contains the halogenated aromatic compound in an organic solvent, a liquid that contains the organometallic compound in an organic solvent, and a liquid that contains the electrophilic compound in an organic solvent in a flow path, while setting the respective water contents of these liquids to 200 ppm or less.
C07D 209/86 - CarbazolesCarbazoles hydrogénés avec uniquement des atomes d'hydrogène, des radicaux hydrocarbonés ou des radicaux hydrocarbonés substitués, liés directement aux atomes de carbone du système cyclique
A first problem to be addressed by the present invention is to provide a two-liquid curable composition: in which regions irradiated with light are cured rapidly; with which a curable composition having excellent curability of unirradiated regions can be produced; and which is configured so that a cured product obtained by curing the curable composition exhibits excellent heat resistance. A second problem to be addressed by the present invention is to provide a method for producing a cured product. A third problem to be addressed by the present invention is to provide an electronic component and a method for producing an electronic component. This two-liquid curable composition is constituted from a curing agent including a compound A and a main agent including a compound B and a compound C. The curing agent and/or the main agent contains at least one type of compound selected from the group consisting of a photobase generator and a compound having a nitroxy radical group. The curing agent and/or the main agent contains a thermally conductive filler.
An object of the present invention is to provide a simple purifying method, measuring method, and kit. The present invention is an oxytocin purifying method including treating a sample with an acid or a salt thereof, and treating the sample treated with the acid or the salt thereof with a hydrophobic carrier, and related to the purifying method, measuring method including the purifying method, and kit, in which the acid or the salt thereof is at least one or more acids or salts thereof selected from the group consisting of hydrochloric acid, acetic acid, sulfuric acid, sodium hydrogensulfate, potassium hydrogensulfate, lithium hydrogensulfate, ammonium sulfate, and a mixture thereof, and the hydrophobic carrier is a hydrophobic carrier having at least one or more functional groups on the surface, selected from the group consisting of an alkyl group having 4 to 6 carbon atoms, an alkylene glycol group, and a phenyl group.
G01N 33/74 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des hormones
The present invention addresses a first problem of providing a coloring composition that, with respect to the coloring of polyamide fiber-containing fabric, can yield a colored article having an excellent cyan hue and also an excellent lightfastness. The present invention additionally addresses a second problem of providing a method for producing a colored article, providing a colored article, and providing a kit, each of which uses the indicated coloring composition. The coloring composition according to the present invention is used to color polyamide fiber-containing fabric, and contains a colorant wherein said colorant contains at least one selection from the group consisting of compounds represented by general formula (1) and compounds represented by general formula (2).
C09B 29/20 - Colorants monoazoïques préparés par diazotation et copulation à partir de copulants ne contenant comme groupe orienteur qu'un groupe hydroxyle o-Hydroxycarbonamides des séries du naphtalène
D06B 11/00 - Traitement limité à certaines parties de matières textiles, p. ex. teinture partielle
C09D 11/328 - Encres pour l'impression à jet d'encre caractérisées par des agents colorants caractérisées par des colorants
The present invention has an object to provide a phosphoramidite activator that improves a solubility of 5-benzylthio-1H-tetrazole in acetonitrile and does not reduce the yield and a purity of a target product.
The present invention relates to a phosphoramidite activator containing (i) at least one compound that is selected from the group consisting of piperidine, pyrrolidine, N-alkylpiperidine, and N-alkylpyrrolidine, (ii) 5-benzylthio-1H-tetrazole, and (iii) acetonitrile; and a method for activating a phosphoramidite and a method for synthesizing a phosphate ester or a thiophosphate ester, both methods using the activator.
C07F 9/6524 - Composés hétérocycliques, p. ex. contenant du phosphore comme hétéro-atome du cycle comportant au moins quatre atomes d'azote comme uniques hétéro-atomes du cycle
Provided is a phthalocyanine pigment represented by general formula (1), the pigment having at least one diffraction peak at 3°≤2θ≤7° in the powder X-ray diffraction spectrum.
Provided are a polycarbonate resin which contains structural units (A) to (C) represented by formulae (A) to (C) at a ratio of (A):(B):(C) = 25-45 mol%:25-45 mol%:15-50 mol%, and a molded article which contains this polycarbonate resin. In the formulae, R1represents an aliphatic hydrocarbon group having 6 or more carbon atoms; R2represents a hydrogen atom or a substituent; R3represents a substituent; n represents an integer of 0 to 8; m represents an integer of (4 + n) or less; R4represents a hydrogen atom or an aliphatic hydrocarbon group having 1 to 5 carbon atoms; meanwhile, the R1and R2moieties, and the R4 moieties do not combine with each other to form a ring; and * denotes a bonding hand. The 1,4-phenylene group in the formulae may be substituted by an aliphatic hydrocarbon group and/or an aromatic hydrocarbon group.
The present invention addresses the problem of providing a solid phase carrier for nucleic acid synthesis which enables, when a nucleic acid is synthesized using the same and cut out, easy separation of the nucleic acid from an adduct by HPLC, a compound which serves as a linker of the solid phase carrier, a compound which is a precursor of the linker, and a nucleic acid production method using the solid phase carrier. The compound of the present invention is represented by general formula (1). In general formula (1): Ar represents an optionally substituted tricyclic or tetracyclic aromatic ring; Z represents a hydrogen atom or a protecting group removable by an acid; and R1to R4 independently represent a hydrogen atom, an alkyl group or an alkoxy group.
C07H 21/04 - Composés contenant au moins deux unités mononucléotide comportant chacune des groupes phosphate ou polyphosphate distincts liés aux radicaux saccharide des groupes nucléoside, p. ex. acides nucléiques avec le désoxyribosyle comme radical saccharide
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
18.
CLATHRATE COMPOUND AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, RESIN COMPOSITION, POLYMER, CURED PRODUCT, AND LAMINATE
A clathrate compound containing a host molecule and a guest molecule in which the host molecule is a compound represented by formula (1) or a cyclic oligosaccharide and the guest molecule is a squarylium compound represented by formula (2), and a method for producing the same, a polymerizable composition, a resin composition, a polymer, a cured product, and a laminate [in formula (1), R1to R12represent a hydrogen atom or a substituent, n1 and n3 represent an integer of 0-3, n2 and n4 represent an integer of 0-4, and ring A and ring B represent an aromatic ring. In formula (2), R21, R23, R25, and R27 represent a hydrogen atom or a substituent, and ring C represents an aromatic ring. Where, at least one of substituents in formula (2) represents a group containing a polymerizable group having an ethylenically unsaturated bond.].
C09B 57/00 - Autres colorants synthétiques de structure connue
B32B 27/30 - Produits stratifiés composés essentiellement de résine synthétique comprenant une résine vinyliqueProduits stratifiés composés essentiellement de résine synthétique comprenant une résine acrylique
C07D 207/34 - Composés hétérocycliques contenant des cycles à cinq chaînons, non condensés avec d'autres cycles, ne comportant qu'un atome d'azote comme unique hétéro-atome du cycle avec uniquement des atomes d'hydrogène ou de carbone liés directement à l'atome d'azote du cycle comportant deux liaisons doubles entre chaînons cycliques ou entre chaînons cycliques et chaînons non cycliques avec des hétéro-atomes ou avec des atomes de carbone comportant trois liaisons à des hétéro-atomes, avec au plus une liaison à un halogène, p. ex. radicaux ester ou nitrile, liés directement aux atomes de carbone du cycle
C08F 2/44 - Polymérisation en présence d'additifs, p. ex. plastifiants, matières colorantes, charges
C08F 20/36 - Esters contenant de l'azote contenant de l'oxygène en plus de l'oxygène de la fonction carboxyle
C08L 33/14 - Homopolymères ou copolymères des esters d'esters contenant des atomes d'halogène, d'azote, de soufre ou d'oxygène en plus de l'oxygène du radical carboxyle
C08L 101/00 - Compositions contenant des composés macromoléculaires non spécifiés
C09B 67/42 - Préparations à base de colorants non prévues dans un seul des groupes
19.
BINDER COMPOSITION FOR SECONDARY BATTERY, COMPOSITION FOR ELECTRODE, ELECTRODE SHEET, SECONDARY BATTERY, MANUFACTURING METHOD FOR SAID ELECTRODE SHEET, AND MANUFACTURING METHOD FOR SAID SECONDARY BATTERY
A binder composition for a secondary battery, said binder composition including water-soluble macromolecules (X), a water-soluble compound (Y), and polymer particles, wherein the water-soluble macromolecules (X) are a polymer that includes a constituent component having a prescribed structure, and the binder composition satisfies properties in which the tensile elastic modulus of the binder composition is 1500-9800 MPa, and as measured according to specific parameters, the difference in the storage elastic modulus at shear strains of 0.01% and 10% is 100-1000 Pa. Additionally, an electrode sheet, a secondary battery, a manufacturing method for said electrode sheet, and a manufacturing method for said secondary battery.
SECONDARY BATTERY BINDER COMPOSITION, ELECTRODE COMPOSITION, ELECTRODE SHEET, AND SECONDARY BATTERY, AND PRODUCTION METHODS FOR SAID ELECTRODE SHEET AND SECONDARY BATTERY
The present invention pertains to: a secondary battery binder composition, an electrode composition, an electrode sheet, and a secondary battery, all of which include a water-soluble polymer (X) formed through polymerization using an azo polymerization initiator, a water-soluble compound (Y), polymer particles, and water; and production methods for said electrode sheet and secondary battery.
C08L 33/08 - Homopolymères ou copolymères des esters de l'acide acrylique
C08L 33/26 - Homopolymères ou copolymères de l'acrylamide ou de la méthacrylamide
C08L 101/00 - Compositions contenant des composés macromoléculaires non spécifiés
C08L 101/14 - Compositions contenant des composés macromoléculaires non spécifiés caractérisées par des propriétés physiques, p. ex. anisotropie, viscosité ou conductivité électrique les composés macromoléculaires étant solubles dans l'eau ou gonflables dans l'eau, p. ex. gels aqueux
H01G 11/38 - Pâtes ou mélanges de carboneLiants ou additifs
H01M 4/13 - Électrodes pour accumulateurs à électrolyte non aqueux, p. ex. pour accumulateurs au lithiumLeurs procédés de fabrication
H01M 4/131 - Électrodes à base d'oxydes ou d'hydroxydes mixtes, ou de mélanges d'oxydes ou d'hydroxydes, p. ex. LiCoOx
H01M 4/133 - Électrodes à base de matériau carboné, p. ex. composés d'intercalation du graphite ou CFx
H01M 4/134 - Électrodes à base de métaux, de Si ou d'alliages
The present invention provides: a binder composition for a secondary battery, the binder composition containing a water-soluble polymer (X) and a water-soluble polymer (Y), wherein the water-soluble polymer (X) is a polymer containing 20% by mass or more of a constituent having a specific structure represented by general formula (B-2), and the ratio of the weight-average molecular weight of the water-soluble polymer (Y) to the weight-average molecular weight of the water-soluble polymer (X) is 0.300-10.0; an electrode sheet and a secondary battery; and a method for producing the electrode sheet and the secondary battery.
C08L 101/14 - Compositions contenant des composés macromoléculaires non spécifiés caractérisées par des propriétés physiques, p. ex. anisotropie, viscosité ou conductivité électrique les composés macromoléculaires étant solubles dans l'eau ou gonflables dans l'eau, p. ex. gels aqueux
H01M 4/13 - Électrodes pour accumulateurs à électrolyte non aqueux, p. ex. pour accumulateurs au lithiumLeurs procédés de fabrication
H01M 4/134 - Électrodes à base de métaux, de Si ou d'alliages
Provided is a method for producing a reversible addition-fragmentation chain transfer polymerization polymer, which includes continuously rotating a reaction container accommodating a mixed solution which contains a monomer and a reversible addition-fragmentation chain transfer agent around a rotation axis inclined with respect to a vertical direction using a rotating photopolymerization reactor, while stirring a liquid pool of the mixed solution, to spread a mixed solution emerging from the liquid pool in a form of a film on an interior wall of the reaction container, and irradiating the mixed solution spread in the form of a film with light from a light source disposed outside the reaction container.
Provided is a method for producing a thiocarbonylthio group-removed polymer, including a step of irradiating a mixed solution which contains a polymer having a thiocarbonylthio group at a terminal of a main chain and contains at least one hydroxyl group-containing compound of an alcohol compound or a phenol compound to remove the thiocarbonylthio group from the polymer.
Provided are a compound represented by formula (X), a method for producing same, a polymerizable composition, a resin composition, a polymer, a cured product, and a laminate [In formula (X), R1, R3, R5, and R7each independently represent a hydrogen atom or a substituent. R1and R3, R3and R5, and R5and R7 may each bond to form a ring. Ring A represents an aromatic ring. Herein, at least one of substituents in formula (X) represents a group containing a polymerizable group having an ethylenically unsaturated bond.].
C09B 57/00 - Autres colorants synthétiques de structure connue
B32B 27/20 - Produits stratifiés composés essentiellement de résine synthétique caractérisée par l'emploi d'additifs particuliers utilisant des charges, des pigments, des agents thixotropiques
C08F 2/44 - Polymérisation en présence d'additifs, p. ex. plastifiants, matières colorantes, charges
C08F 2/48 - Polymérisation amorcée par énergie ondulatoire ou par rayonnement corpusculaire par la lumière ultraviolette ou visible
C08F 20/00 - Homopolymères ou copolymères de composés contenant un ou plusieurs radicaux aliphatiques non saturés, chaque radical ne contenant qu'une seule liaison double carbone-carbone et un seul étant terminé par un seul radical carboxyle ou un sel, anhydride, ester, amide, imide ou nitrile
C08F 20/02 - Acides monocarboxyliques contenant moins de dix atomes de carboneLeurs dérivés
C08F 265/04 - Composés macromoléculaires obtenus par polymérisation de monomères sur des polymères d'acides monocarboxyliques non saturés ou de leurs dérivés tels que définis dans le groupe sur des polymères d'esters
C08L 51/06 - Compositions contenant des polymères greffés dans lesquels le composant greffé est obtenu par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carboneCompositions contenant des dérivés de tels polymères greffés sur des homopolymères ou des copolymères d'hydrocarbures aliphatiques ne contenant qu'une seule liaison double carbone-carbone
C08L 101/00 - Compositions contenant des composés macromoléculaires non spécifiés
C09B 67/20 - Préparations à base de pigments organiques
C09B 69/10 - Colorants polymèresProduits de réactions de colorants avec des monomères ou avec des composés macromoléculaires
A measuring device according to the present disclosure comprises: a measuring unit for measuring a target substance contained in a sample solution; a tool storage space in which tools used for the measurement are placed, and which is disposed above the measuring unit in a vertical direction; a dispensing unit which dispenses a liquid and which is capable of moving above the tool storage space; and a housing for accommodating the measuring unit, the tool storage space, and the dispensing unit.
G01N 35/10 - Dispositifs pour transférer les échantillons vers, dans ou à partir de l'appareil d'analyse, p. ex. dispositifs d'aspiration, dispositifs d'injection
26.
SECONDARY BATTERY BINDER COMPOSITION, ELECTRODE COMPOSITION, ELECTRODE SHEET, SECONDARY BATTERY, PRODUCTION METHOD FOR ELECTRODE SHEET, AND PRODUCTION METHOD FOR SECONDARY BATTERY
Provided is a secondary battery binder composition containing a water-soluble crosslinked polymer obtained by crosslinking a copolymer containing a (meth)acrylic acid component and a (meth)acrylic acid ester component as constitutional components by an aziridine compound, and water. Also provided are an electrode composition, an electrode sheet, a secondary battery, a production method for the electrode sheet, and a production method for the secondary battery.
C08F 220/18 - Esters des alcools ou des phénols monohydriques des phénols ou des alcools contenant plusieurs atomes de carbone avec l'acide acrylique ou l'acide méthacrylique
In this styrenic polymer production method, a monomer including a styrene compound is polymerized at 110°C or greater in the presence of a reversible addition-fragmentation chain transfer agent and an azo polymerization initiator whose 10-hour half-life temperature is 90°C or greater.
The present invention provides a fluorinated phthalocyanine compound represented by formula (1) and an application thereof. (In the formula, M represents a metal atom or an oxide of a metal atom; each of R101, R102, R103, R104, R105, R106, R107and R108independently represents a substituted or unsubstituted alkyl group or the like, provided that at least one of the two groups in each of combination A of R101and R102, combination B of R103and R104, combination C of R105and R106, and combination D of R107and R108represents a substituted or unsubstituted alkyl group, and it is not possible that all of R101, R102, R103, R104, R105, R106, R107and R1082222ppR1q2q2q)NR2R3.)
BINDER COMPOSITION FOR SECONDARY BATTERIES, ELECTRODE SHEET, SECONDARY BATTERY, METHOD FOR PRODUCING ELECTRODE SHEET AND METHOD FOR PRODUCING SECONDARY BATTERY
The present invention provides: a binder composition for secondary batteries, the binder composition containing a water-soluble polymer (X), a water-soluble polymer (Y) and polymer particles, wherein the water-soluble polymer (X) comprises a constituent having a specific structure, and the ratio of the tensile elastic modulus of the water-soluble polymer (X) to the tensile elastic modulus of the polymer particles is more than 10; an electrode sheet; a secondary battery; a method for producing the electrode sheet; and a method for producing the secondary battery.
A fluorinated phthalocyanine compound represented by formula (1) and the application thereof (In formula (1), M represents a metal atom or an oxide of a metal atom, R101-R108each independently represent an alkyl group, an aryl group, or a heterocyclic group. Where, at least one of R101-R108is a group represented by formula (2). In formula (2), R201-R205each independently represent a hydrogen atom or a monovalent substituent. Where, at least one of R201-R205 is any one group selected from the group consisting of formula (3), formula (4), formula (5), formula (6), and formula (7).).
B41M 5/00 - Procédés de reproduction ou méthodes de reproduction ou de marquageMatériaux en feuilles utilisés à cet effet
C09B 67/20 - Préparations à base de pigments organiques
B41J 2/01 - Machines à écrire ou mécanismes d'impression sélective caractérisés par le procédé d'impression ou de marquage pour lequel ils sont conçus caractérisés par la mise en contact sélective d'un liquide ou de particules avec un matériau d'impression à jet d'encre
31.
METHOD FOR MANUFACTURING PHOSPHONATE ESTERS AND METHOD FOR MANUFACTURING PHOSPHATE ESTERS
The present invention provides a method for efficiently manufacturing a phosphonate ester by phosphonylating an alcohol under mild conditions, and a method for manufacturing a phosphate ester. In the method for manufacturing a phosphonate ester of the present invention, a compound represented by the formula (1) is reacted with a compound represented by the formula (2) in the presence of a zinc catalyst to obtain a compound represented by the formula (3).
The present invention provides a method for efficiently manufacturing a phosphonate ester by phosphonylating an alcohol under mild conditions, and a method for manufacturing a phosphate ester. In the method for manufacturing a phosphonate ester of the present invention, a compound represented by the formula (1) is reacted with a compound represented by the formula (2) in the presence of a zinc catalyst to obtain a compound represented by the formula (3).
The present invention provides a method for efficiently manufacturing a phosphonate ester by phosphonylating an alcohol under mild conditions, and a method for manufacturing a phosphate ester. In the method for manufacturing a phosphonate ester of the present invention, a compound represented by the formula (1) is reacted with a compound represented by the formula (2) in the presence of a zinc catalyst to obtain a compound represented by the formula (3).
X represents an organic group. R1 represents an alkyl group. R2 represents an organic group.
C07F 9/145 - Esters des acides phosphoreux avec des composés hydroxyarylés
C07H 19/10 - Radicaux pyrimidine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques
C07H 19/207 - Radicaux purine avec le radical saccharide estérifié par des acides phosphoriques ou polyphosphoriques les acides phosphoriques ou polyphosphoriques étant estérifiés par un autre composé hydroxylique, p. ex. les dinucléotides de la flavine-adénine ou de la nicotinamide-adénine
C07F 9/143 - Esters des acides phosphoreux avec des alcools acycliques non saturés
B01J 31/04 - Catalyseurs contenant des hydrures, des complexes de coordination ou des composés organiques contenant des composés organiques ou des hydrures métalliques contenant des acides carboxyliques ou leurs sels
32.
METHOD FOR PRODUCING HALOGENOBICYCLO[1.1.1]PENTANE
A method for producing a halogenobicyclo[1.1.1]pentane comprising: a step (a) in which [1.1.1]propellane is obtained by causing a reaction between 1,1-dibromo-2,2-bis(chloromethyl)cyclopropane and an organometallic reagent in a solvent containing a non-cyclic ether having five or more carbon atoms; and a step (b) in which a halogenobicyclo[1.1.1]pentane is obtained by reacting the obtained [1.1.1]propellane with a halogen in a state in which light having a wavelength of 400 nm or less is blocked.
A production method for an encapsulation of a bicycloalkane compound, the method comprising mixing a bicycloalkane compound and a cyclodextrin compound in a mixed solvent of water and an organic solvent.
C07C 17/42 - Emploi d'additifs, p. ex. pour la stabilisation
C07B 63/02 - PurificationSéparation spécialement adaptée aux fins d'isolement des composés organiquesStabilisationEmploi d'additifs par un traitement donnant lieu à une modification chimique
C07C 23/20 - Hydrocarbures halogénés polycycliques à cycles condensés dont aucun n'est aromatique
34.
METHOD FOR PRODUCING 1,3-DISUBSTITUTED BICYCLO[1.1.1]PENTANE BY PHOTOREACTION
A method for producing 1,3-disubstituted bicyclo[1.1.1]pentanes which allow the co-existence of a cyclic ether compound in a reaction solution when obtaining a 1,3-disubstituted bicyclo[1.1.1]pentane by causing [1.1.1]propellane and a 1,2-diketone compound to undergo a photoreaction in a solvent containing a non-cyclic ether solvent having five or more carbon atoms.
C07C 45/68 - Préparation de composés comportant des groupes C=O liés uniquement à des atomes de carbone ou d'hydrogènePréparation des chélates de ces composés par des réactions ne créant pas de groupe C=O par isomérisationPréparation de composés comportant des groupes C=O liés uniquement à des atomes de carbone ou d'hydrogènePréparation des chélates de ces composés par des réactions ne créant pas de groupe C=O par modification de la taille du squelette carboné par augmentation du nombre d'atomes de carbone
C07C 49/323 - Composés saturés comportant des groupes cétone liés à des cycles polycycliques avec les groupes cétones liés à des systèmes cycliques condensés
35.
EMULSION COMPOSITION, AND SKIN TOPICAL AGENT AND COSMETIC CONTAINING SAID COMPOSITION
The purpose of the present is to provide an oil-in-water (O/W) emulsion composition which the user perceives as fresh at the time of application and as thick after application (after spreading out), and which can coexist with electrolytes in the composition. The present invention relates to: an oil-in-water (O/W) emulsion composition which contains an oil-base component in the emulsion particles, wherein the emulsion composition includes a component A and the oil-base component, the content of component A is 0.4-250 mass% with respect to the oil-base component, the emulsion composition contains substantially no surfactant, and in the case of containing surfactant, the content of said surfactant is less than or equal to 90 mass% with respect to component A and less than or equal to 3 mass% with respect to the oil-base component, and the content of the oil-base component in the emulsion composition is 1-65%; a skin topical agent and a cosmetic that contain said emulsion composition; and a production method of said emulsion composition. Component A: an acrylic acid ester (a) / compound (b) copolymer which comprises as constituent components an acrylic acid ester (a) that is represented in general formula [1] and a compound (b) that has, in the molecule, a polymerizable unsaturated group and a functional group that is selected from among a carboxyl group, a sulfo group and a phosphate group, wherein the ratio (mass ratio) of the acrylic acid ester (a) and the compound (b) is (a)/(b) = 6.0/94.0-30.0/70.0. General formula [1]: (in the formula, R1 represents a hydrogen atom or an alkyl group with 1-6 carbons, and m represents an integer 2-4.)
A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes Huiles, graisses ou cires naturelles ou naturelles modifiées, p. ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
B01J 13/00 - Chimie des colloïdes, p. ex. production de substances colloïdales ou de leurs solutions, non prévue ailleursFabrication de microcapsules ou de microbilles
A61K 8/81 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons insaturées carbone-carbone
A61K 8/92 - Huiles, graisses ou ciresLeurs dérivés, p. ex. produits d'hydrogénation
C09K 23/52 - Résines naturelles ou synthétiques ou leurs sels
36.
COMPOUND, PIGMENT, INK SHEET FOR THERMOSENSITIVE TRANSFER RECORDING
The present invention addresses the problem of providing a novel polymer compound which, even if said compound does not include repeating units derived from monomers having fluorine atoms, can form a viscous aqueous solution having a desired viscosity even in the presence of a polyelectrolyte such as magnesium L-ascorbyl phosphate. Further provided are a cosmetic and a thickener containing the above-mentioned polymer. This polymer compound comprises a repeating unit derived from a monomer (A) having an acidic functional group and an ethylenically unsaturated double bond group, a repeating unit derived from a monomer (B) having an ethylenically unsaturated double bond group not containing fluorine atoms, and a repeating unit derived from a monomer (C) having two or more ethylenically unsaturated double bond group, wherein the monomer (B) includes a compound represented by formula (1) and a compound represented by formula (2).
C08F 220/04 - AcidesLeurs sels métalliques ou leurs sels d'ammonium
A61K 8/81 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons insaturées carbone-carbone
A61Q 1/02 - Préparations contenant des colorants cutanés, p. ex. pigments
A61Q 1/10 - Préparations contenant des colorants cutanés, p. ex. pigments pour les yeux, p. ex. eye-liner, mascara
A61Q 5/02 - Préparations pour le lavage des cheveux
A61Q 5/04 - Préparations pour onduler de façon permanente ou décrêper les cheveux
A61Q 5/06 - Préparations pour mettre les cheveux en forme, p. ex. pour mettre en forme ou colorer temporairement
A61Q 5/10 - Préparations pour la teinture permanente des cheveux ou des poils
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
A61Q 19/00 - Préparations pour les soins de la peau
A61Q 19/10 - Préparations pour le nettoyage ou le bain
C08F 220/06 - Acide acryliqueAcide méthacryliqueLeurs sels métalliques ou leurs sels d'ammonium
Provided is a manufacturing method for a polymer having a thiocarbonylthio group removed, said method comprising a step for removing a thiocarbonylthio group from a polymer by radiating light onto a mixture containing a polymer, that has a thiocarbonylthio group at the end of a main chain, and at least one hydroxyl group-containing compound of an alcohol compound and a phenol compound.
A composition for a negative electrode, which comprises a binder comprising a water-soluble polymer and carbon-coated silicon oxide, in which the water-soluble polymer has a ratio of adsorption of the carbon-coated silicon oxide of 5 to 25%; a negative electrode sheet and a non-aqueous secondary battery, each of which is produced using the composition for a negative electrode; and a method for producing the negative electrode sheet and a method for producing the non-aqueous secondary battery.
C08L 33/04 - Homopolymères ou copolymères des esters
C08L 33/26 - Homopolymères ou copolymères de l'acrylamide ou de la méthacrylamide
C08L 101/14 - Compositions contenant des composés macromoléculaires non spécifiés caractérisées par des propriétés physiques, p. ex. anisotropie, viscosité ou conductivité électrique les composés macromoléculaires étant solubles dans l'eau ou gonflables dans l'eau, p. ex. gels aqueux
H01M 4/13 - Électrodes pour accumulateurs à électrolyte non aqueux, p. ex. pour accumulateurs au lithiumLeurs procédés de fabrication
H01M 4/131 - Électrodes à base d'oxydes ou d'hydroxydes mixtes, ou de mélanges d'oxydes ou d'hydroxydes, p. ex. LiCoOx
Provided is a method for producing a polymer by reversible addition-fragmentation chain transfer polymerization in which a rotary photopolymerization reactor is used, the method comprising: continuously rotating a reaction vessel containing a liquid mixture comprising a monomer and a reversible addition-fragmentation chain transfer agent on a rotation axis slanting off from the vertical direction to thereby stir a collected portion of the liquid mixture and allow some of the liquid mixture to spread in the shape of a film on the inner wall of the reaction vessel which is appearing from the collected portion; and irradiating the filmily spread liquid mixture with light from a light source disposed outside the reaction vessel.
C08F 2/48 - Polymérisation amorcée par énergie ondulatoire ou par rayonnement corpusculaire par la lumière ultraviolette ou visible
41.
BINDER FOR SECONDARY BATTERIES, BINDER COMPOSITION FOR SECONDARY BATTERIES, COMPOSITION FOR ELECTRODES, ELECTRODE SHEET, SECONDARY BATTERY, METHOD FOR PRODUCING ELECTRODE SHEET, AND METHOD FOR PRODUCING SECONDARY BATTERY
A binder for secondary batteries, the binder containing a water-soluble block polymer that has, in the polymer main chain, a segment A which is composed of a chain polymerized polymer that has a glass transition temperature of 150°C or more and a segment B which is composed of a chain polymerized polymer that has a glass transition temperature of less than 150°C; a binder composition for secondary batteries; a composition for electrodes; an electrode sheet; a secondary battery; a method for producing an electrode sheet; and a method for producing a secondary battery.
The present invention relates to a composition for a negative electrode comprising a binder and carbon-coated silicon oxide, wherein the binder includes 5% by mass or more of a water-soluble polymer, the water-soluble polymer has a weight average molecular weight of 300,000 or less, and the proportion of an acid group-containing component in the water-soluble polymer is 5% by mass or less, and also to a negative electrode sheet and a non-aqueous secondary battery produced using this composition for a negative electrode, and a method for manufacturing the negative electrode sheet and non-aqueous secondary battery.
C08L 33/04 - Homopolymères ou copolymères des esters
C08L 33/26 - Homopolymères ou copolymères de l'acrylamide ou de la méthacrylamide
C08L 101/14 - Compositions contenant des composés macromoléculaires non spécifiés caractérisées par des propriétés physiques, p. ex. anisotropie, viscosité ou conductivité électrique les composés macromoléculaires étant solubles dans l'eau ou gonflables dans l'eau, p. ex. gels aqueux
H01M 4/13 - Électrodes pour accumulateurs à électrolyte non aqueux, p. ex. pour accumulateurs au lithiumLeurs procédés de fabrication
A method for assisting the diagnosis of Alzheimer's disease, comprising: measuring an amount of extracellular vesicles having phosphatidylserine and tetraspanin, or the amount of extracellular vesicles having phosphatidylserine and tetraspanin and an amount of extracellular vesicles having tetraspanin, in a biological specimen derived from a subject; and determining that the subject has Alzheimer's disease using the amount of extracellular vesicles having phosphatidylserine and tetraspanin, or a ratio of the amount of extracellular vesicles having phosphatidylserine and tetraspanin to the amount of extracellular vesicles having tetraspanin as an indicator.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
44.
METHOD FOR ASSISTING DIAGNOSIS OF PARKINSON'S DISEASE, BIOMARKER, REAGENT KIT, AND DEVICE
A method for assisting the diagnosis of Parkinson's disease, including:
measuring an amount of extracellular vesicles having phosphatidylserine and tetraspanin, or the amount of extracellular vesicles having phosphatidylserine and tetraspanin and an amount of extracellular vesicles having tetraspanin, in a biological specimen derived from a subject; and
determining that the subject has Parkinson's disease using the amount of extracellular vesicles having phosphatidylserine and tetraspanin, or a ratio of the amount of extracellular vesicles having phosphatidylserine and tetraspanin to the amount of extracellular vesicles having tetraspanin as an indicator.
G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
G01N 33/53 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet
G01N 33/92 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des lipides, p. ex. le cholestérol
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
45.
OXYTOCIN PURIFYING METHOD AND MEASURING METHOD AND KIT
The present invention addresses the problem of providing a simple oxytocin purifying method and measuring method and kit. The present invention pertains to an oxytocin purifying method, comprising treating a sample with an acid or a salt thereof and treating the sample treated with the acid or a salt thereof with a hydrophobic carrier, wherein the acid or a salt thereof is at least one acid or salt thereof selected from the group consisting of hydrochloric acid, acetic acid, sulfuric acid, sodium hydrogen sulfate, potassium hydrogen sulfate, lithium hydrogen sulfate, ammonium sulfate and mixtures thereof, and the hydrophobic carrier is a hydrophobic carrier having at least one functional group selected from the group consisting of C4-6 alkyl groups, alkylene glycol groups and phenyl group on the surface thereof, and a measuring method and kit comprising the purifying method.
C07K 7/06 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 5 à 11 amino-acides
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
A problem addressed by the present invention is to provide a method for producing a dicarboxylate monoester having excellent dicarboxylate monoester selectivity and yield. The method for producing a dicarboxylate monoester of the present invention is a method for producing a dicarboxylate monoester that reacts a dicarboxylic acid represented by formula (1) with an alcohol derivative represented by formula (2) using a base in a mixed solvent of water and a hydrophobic solvent and produces a dicarboxylate monoester represented by formula (3) or (4).
C07C 67/11 - Préparation d'esters d'acides carboxyliques par réaction d'acides carboxyliques ou d'anhydrides symétriques avec des groupes ester ou avec une liaison carbone-halogène avec des groupes ester minéraux
C07C 69/753 - Esters d'acides carboxyliques dont un groupe carboxyle est lié à un atome de carbone d'un cycle autre qu'un cycle aromatique à six chaînons d'acides polycycliques
The present invention addresses the problem of providing: an adsorption inhibitor for hepcidin; a method for inhibiting adsorption; a reference standard; a reagent; a kit; and a measurement method. The present invention relates to: an adsorption inhibitor for hepcidin, said adsorption inhibitor containing a chelating agent; a method for inhibiting the adsorption of hepcidin, said method comprising a step wherein a hepcidin-containing liquid is brought into contact with at least one member that is selected from among rubber members, plastic members and glass members in the presence of a chelating agent; a reference standard for hepcidin measurement, said reference standard containing hepcidin and an adsorption inhibitor for hepcidin; and the like. The present invention inhibits the adsorption of hepcidin.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
48.
Binder for electricity storage devices improving dispersibility of conductive assistant
An object of the present invention is to provide a binder which exhibits excellent dispersibility of a conductive assistant; a slurry composition and an electrode, each of which uses this binder; and an electricity storage device which is provided with this electrode.
2/g or less; a slurry composition and an electrode, each of which uses this binder; an electricity storage device which is provided with this electrode; and the like.
H01M 4/133 - Électrodes à base de matériau carboné, p. ex. composés d'intercalation du graphite ou CFx
H01B 1/24 - Matériau conducteur dispersé dans un matériau organique non conducteur le matériau conducteur comportant des compositions à base de carbone-silicium, du carbone ou du silicium
C08F 220/06 - Acide acryliqueAcide méthacryliqueLeurs sels métalliques ou leurs sels d'ammonium
H01M 4/62 - Emploi de substances spécifiées inactives comme ingrédients pour les masses actives, p. ex. liants, charges
C08L 33/08 - Homopolymères ou copolymères des esters de l'acide acrylique
C08L 33/10 - Homopolymères ou copolymères des esters de l'acide méthacrylique
H01M 4/134 - Électrodes à base de métaux, de Si ou d'alliages
C08F 220/28 - Esters contenant de l'oxygène en plus de l'oxygène de la fonction carboxyle ne contenant pas de cycles aromatiques dans la partie alcool
H01G 11/06 - Condensateurs hybrides avec une des électrodes permettant de doper les ions de façon réversible, p. ex. condensateurs lithium-ion
H01G 11/38 - Pâtes ou mélanges de carboneLiants ou additifs
H01M 10/0525 - Batteries du type "rocking chair" ou "fauteuil à bascule", p. ex. batteries à insertion ou intercalation de lithium dans les deux électrodesBatteries à l'ion lithium
H01M 4/02 - Électrodes composées d'un ou comprenant un matériau actif
JAPAN AS REPRESENTED BY THE DIRECTOR-GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES (Japon)
FUJITA ACADEMY (Japon)
Inventeur(s)
Murakami Takahiro
Yoshida Yukihiro
Yagura Yo
Takahashi Yoshimasa
Moriyama Saya
Suzuki Tadaki
Fujigaki Hidetsugu
Abrégé
The present invention pertains to a method for assaying a subject-animal antibody contained in a biological sample of a subject-animal. The method is characterized by comprising bringing an antigen, a biological sample of a subject-animal, and anti-subject-animal immunoglobulin antibodies into contact with each other, and assaying a complex formed of the antigen, a subject-animal antibody, and the anti-subject-animal immunoglobulin antibodies, and is characterized in that the anti-subject-animal immunoglobulin antibodies are a plurality of antibodies against a specific class of immunoglobulin, and include antibodies that cross-react with all subclasses of immunoglobulin in the specific class. The present invention also pertains to a kit for assaying a subject-animal antibody contained in a biological sample of a subject-animal. The kit is characterized by including an antigen and anti-subject-animal immunoglobulin antibodies, and is characterized in that the anti-subject-animal immunoglobulin antibodies are a plurality of antibodies against a specific class of immunoglobulin, and include antibodies that cross-react with all subclasses of immunoglobulin in the specific class.
A first problem of the present invention is to provide a composition having excellent sweat resistance. A second problem of the present invention is to provide a composition for resin coloring and a polymer which have excellent sweat resistance. These compositions of the present invention each comprise a polymer comprising repeating units represented by general formula (1) and repeating units represented by general formula (2) and a thermoplastic resin.
C08F 220/18 - Esters des alcools ou des phénols monohydriques des phénols ou des alcools contenant plusieurs atomes de carbone avec l'acide acrylique ou l'acide méthacrylique
C08L 23/02 - Compositions contenant des homopolymères ou des copolymères d'hydrocarbures aliphatiques non saturés ne possédant qu'une seule liaison double carbone-carboneCompositions contenant des dérivés de tels polymères non modifiées par un post-traitement chimique
C08L 25/18 - Homopolymères ou copolymères de monomères aromatiques contenant des éléments autres que le carbone et l'hydrogène
C08L 33/04 - Homopolymères ou copolymères des esters
C08L 77/00 - Compositions contenant des polyamides obtenus par des réactions créant une liaison amide carboxylique dans la chaîne principaleCompositions contenant des dérivés de tels polymères
C08L 101/02 - Compositions contenant des composés macromoléculaires non spécifiés caractérisées par la présence de groupes déterminés
C08L 101/06 - Compositions contenant des composés macromoléculaires non spécifiés caractérisées par la présence de groupes déterminés contenant des atomes d'oxygène
51.
CULTURE MEDIUM FOR PRODUCING EXTRACELLULAR VESICLES, CULTURE MEDIUM KIT, ADDITIVE, AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES
The present invention addresses the problem of providing a culture medium for producing extracellular vesicles, a culture medium kit, an additive, and a method for producing extracellular vesicles, whereby the production of extracellular vesicles is facilitated. The present invention provides a culture medium for producing extracellular vesicles, the culture medium comprising: a basal culture medium for culturing animal cells; and at least one component selected from L-glutamine or a salt thereof, transferrin, selenous acid or a salt thereof, insulin, an insulin-like growth factor, a serotonin compound, and transforming growth factor β. If the culture medium for producing extracellular vesicles contains L-glutamine or a salt thereof, the concentration of the L-glutamine or salt thereof is 5 mM or greater. The present invention also provides a culture medium kit, an additive, and a method for producing extracellular vesicles.
C12N 5/077 - Cellules mésenchymateuses, p. ex. cellules osseuses, cellules de cartilage, cellules stromales médulaires, cellules adipeuses ou cellules musculaires
52.
SECONDARY BATTERY BINDER COMPOSITION, ELECTRODE COMPOSITION, ELECTRODE SHEET, SECONDARY BATTERY, PRODUCTION METHOD FOR ELECTRODE SHEET, AND PRODUCTION METHOD FOR SECONDARY BATTERY
A secondary battery binder composition that includes water and a water-soluble cross-linked polymer that is formed by using an aziridine compound to cross-link a copolymer that contains, as constituent components, a (meth)acrylic acid component and a (meth)acrylic acid ester component. An electrode composition, an electrode sheet, a secondary battery, a production method for the electrode sheet, and a production method for the secondary battery.
This heat-sensitive transfer recording sheet comprises a base material, and a coloring material layer on the base material, wherein the coloring material layer has a yellow dye layer, a magenta dye layer, and a cyan dye layer, contains a compound represented by general formula (1) as a magenta dye, and contains specific compounds as a yellow dye and a cyan dye. In general formula (1), R11represents a phenyl group or a C1-C4 unsubstituted alkyl group. R12represents a phenyl group or a C1-C4 unsubstituted alkyl group. R13and R14 each represent a C1-C8 alkyl group.
An object of the present invention is to provide a highly practical electrolyte solution which has high oxidation resistance and enables dissolution-precipitation of magnesium to proceed repeatedly and stably.
An object of the present invention is to provide a highly practical electrolyte solution which has high oxidation resistance and enables dissolution-precipitation of magnesium to proceed repeatedly and stably.
The present invention relates to an electrolyte solution for a magnesium battery comprising a mixture of a compound represented by the general formula [1], a Lewis acid or a compound represented by the general formula [4], and a solvent; an electrochemical device containing the electrolyte solution; and a compound represented by the general formula [1].
An object of the present invention is to provide a highly practical electrolyte solution which has high oxidation resistance and enables dissolution-precipitation of magnesium to proceed repeatedly and stably.
The present invention relates to an electrolyte solution for a magnesium battery comprising a mixture of a compound represented by the general formula [1], a Lewis acid or a compound represented by the general formula [4], and a solvent; an electrochemical device containing the electrolyte solution; and a compound represented by the general formula [1].
An object of the present invention is to provide a highly practical electrolyte solution which has high oxidation resistance and enables dissolution-precipitation of magnesium to proceed repeatedly and stably.
The present invention relates to an electrolyte solution for a magnesium battery comprising a mixture of a compound represented by the general formula [1], a Lewis acid or a compound represented by the general formula [4], and a solvent; an electrochemical device containing the electrolyte solution; and a compound represented by the general formula [1].
[In the general formula [1], X1 represents a halogeno group, and R1 represents an alkyl group having 1 to 10 carbon atoms, which may have a group represented by —SO3MgX2 (X2 represents a halogeno group); a haloalkyl group having 1 to 10 carbon atoms, which may have a group represented by —SO3MgX2 (X2 is the same as described above); an aryl group having 6 to 14 carbon atoms, which may have an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a halogeno group, or a group represented by —SO3MgX2 (X2 is the same as described above); or a biphenyl group which may have a group represented by —SO3MgX2 (X2 is the same as described above).]
An object of the present invention is to provide a highly practical electrolyte solution which has high oxidation resistance and enables dissolution-precipitation of magnesium to proceed repeatedly and stably.
The present invention relates to an electrolyte solution for a magnesium battery comprising a mixture of a compound represented by the general formula [1], a Lewis acid or a compound represented by the general formula [4], and a solvent; an electrochemical device containing the electrolyte solution; and a compound represented by the general formula [1].
[In the general formula [1], X1 represents a halogeno group, and R1 represents an alkyl group having 1 to 10 carbon atoms, which may have a group represented by —SO3MgX2 (X2 represents a halogeno group); a haloalkyl group having 1 to 10 carbon atoms, which may have a group represented by —SO3MgX2 (X2 is the same as described above); an aryl group having 6 to 14 carbon atoms, which may have an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a halogeno group, or a group represented by —SO3MgX2 (X2 is the same as described above); or a biphenyl group which may have a group represented by —SO3MgX2 (X2 is the same as described above).]
Mg[N(SO2R4)2]2 [4]
An object of the present invention is to provide a highly practical electrolyte solution which has high oxidation resistance and enables dissolution-precipitation of magnesium to proceed repeatedly and stably.
The present invention relates to an electrolyte solution for a magnesium battery comprising a mixture of a compound represented by the general formula [1], a Lewis acid or a compound represented by the general formula [4], and a solvent; an electrochemical device containing the electrolyte solution; and a compound represented by the general formula [1].
[In the general formula [1], X1 represents a halogeno group, and R1 represents an alkyl group having 1 to 10 carbon atoms, which may have a group represented by —SO3MgX2 (X2 represents a halogeno group); a haloalkyl group having 1 to 10 carbon atoms, which may have a group represented by —SO3MgX2 (X2 is the same as described above); an aryl group having 6 to 14 carbon atoms, which may have an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a halogeno group, or a group represented by —SO3MgX2 (X2 is the same as described above); or a biphenyl group which may have a group represented by —SO3MgX2 (X2 is the same as described above).]
Mg[N(SO2R4)2]2 [4]
(In the general formula [4], four R4's each independently represent an alkyl group having 1 to 6 carbon atoms, a perfluoroalkyl group having 1 to 6 carbon atoms, a phenyl group, or a perfluorophenyl group.)
H01M 10/0569 - Matériaux liquides caracterisés par les solvants
H01M 10/0567 - Matériaux liquides caracterisés par les additifs
H01M 10/0568 - Matériaux liquides caracterisés par les solutés
H01M 10/054 - Accumulateurs à insertion ou intercalation de métaux autres que le lithium, p. ex. au magnésium ou à l'aluminium
C07C 309/04 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant un seul groupe sulfo
C07C 309/06 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant des atomes d'halogène ou des groupes nitro ou nitroso liés au squelette carboné
C07C 309/24 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné contenant des cycles aromatiques à six chaînons
55.
METHOD FOR ASSISTING DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE
The present invention provides a method for assisting the diagnosis of inflammatory bowel disease, whereby inflammatory bowel disease can be specifically identified. The present invention pertains to: a method for assisting diagnosis of inflammatory bowel disease, that includes measurement of human prohaptoglobin in a patient-derived sample, after reducing the sample and by using an antibody 1 that specifically binds to an amino acid sequence represented by SEQ ID NO: 1, and using the human prohaptoglobin amount as an indicator and determining that the patient has inflammatory bowel disease; a method for obtaining data for assisting said diagnosis; and an inflammatory bowel disease diagnostic assistance test kit that includes the antibody 1 and a reducing agent.
G01N 33/53 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet
C12M 1/34 - Mesure ou test par des moyens de mesure ou de détection des conditions du milieu, p. ex. par des compteurs de colonies
56.
NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY BINDER COMPOSITION, ELECTRODE COMPOSITION, ELECTRODE SHEET, NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY, PRODUCTION METHOD FOR ELECTRODE SHEET, AND PRODUCTION METHOD FOR SECONDARY BATTERY
A non-aqueous electrolyte secondary battery binder composition that contains a binder in an aqueous medium that includes water, the binder being formed from a polymer that has a structural component that is represented by formula (J-1), and the water content of the composition being at least 10 mass%. An electrode composition that includes the binder composition and an electrode active material. An electrode sheet that has a layer that is formed from the electrode composition and a production method for the electrode sheet. A non-aqueous electrolyte secondary battery that has, in order, a positive electrode active material layer, a separator, and a negative electrode active material layer, at least one of the active material layers being formed from the electrode composition and a production method for the non-aqueous electrolyte secondary battery.
H01M 4/62 - Emploi de substances spécifiées inactives comme ingrédients pour les masses actives, p. ex. liants, charges
H01G 11/06 - Condensateurs hybrides avec une des électrodes permettant de doper les ions de façon réversible, p. ex. condensateurs lithium-ion
H01G 11/38 - Pâtes ou mélanges de carboneLiants ou additifs
H01G 11/50 - Électrodes caractérisées par leur matériau spécialement adaptées aux condensateurs lithium-ion, p. ex. pour doper le lithium ou pour intercalation
H01G 11/86 - Procédés de fabrication de condensateurs hybrides ou EDL ou de leurs composants spécialement adaptés pour les électrodes
BINDER COMPOSITION FOR NONAQUEOUS SECONDARY BATTERY, COMPOSITION FOR ELECTRODE, ELECTRODE SHEET, NONAQUEOUS SECONDARY BATTERY, AND METHODS FOR PRODUCING SAID ELECTRODE SHEET AND SAID NONAQUEOUS SECONDARY BATTERY
Provided are: a binder composition for nonaqueous secondary batteries which includes a binder constituted of a polymer having a component including a betaine structure; a composition for electrodes which comprises said binder composition and an electrode active material; an electrode sheet including a layer constituted of said composition for electrodes; a method for producing the electrode sheet; a nonaqueous secondary battery including a positive-electrode active material layer and a negative-electrode active material layer, wherein at least one of the layers is a layer constituted of said composition for electrodes; and a method for producing the nonaqueous secondary battery.
H01M 4/62 - Emploi de substances spécifiées inactives comme ingrédients pour les masses actives, p. ex. liants, charges
H01G 11/06 - Condensateurs hybrides avec une des électrodes permettant de doper les ions de façon réversible, p. ex. condensateurs lithium-ion
H01G 11/38 - Pâtes ou mélanges de carboneLiants ou additifs
H01G 11/50 - Électrodes caractérisées par leur matériau spécialement adaptées aux condensateurs lithium-ion, p. ex. pour doper le lithium ou pour intercalation
H01G 11/86 - Procédés de fabrication de condensateurs hybrides ou EDL ou de leurs composants spécialement adaptés pour les électrodes
The present invention addresses the problem of providing a cellular aging inhibitor, a biological tissue repair promoter, a gene expression regulator, and a topical skin composition constituted from a population of extracellular vesicles having high cell aging inhibitory activity and/or biological tissue repair promoting activity. The present invention pertains to a cellular aging inhibitor, a biological tissue repair promoter, a gene expression regulator, and a topical skin composition having, as an active ingredient, extracellular vesicles derived from mesenchymal stem cells, wherein the extracellular vesicles are derived from mesenchymal stem cells stimulated by inflammatory cytokines, and/or the extracellular vesicles are obtained by a method utilizing a substance having an affinity for phosphatidylserine.
A61K 35/28 - Moelle osseuseCellules souches hématopoïétiquesCellules souches mésenchymateuses de toutes origines, p. ex. cellules souches dérivées de tissu adipeux
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
A61K 45/00 - Préparations médicinales contenant des ingrédients actifs non prévus dans les groupes
A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
59.
METHOD FOR MANUFACTURING PHOSPHONATE ESTERS AND METHOD FOR MANUFACTURING PHOSPHATE ESTERS
The present invention provides a method for efficiently manufacturing phosphonate esters by phosphonylating an alcohol under mild conditions and a method for manufacturing phosphate esters. In this method for manufacturing phosphonate esters, a compound represented by the formula (1) and a compound represented by the formula (2) are allowed to react in the presence of a zinc catalyst to obtain a compound represented by the formula (3). Formula (1): X-OH X represents an organic group. R1represents an alkyl group. R2 represents an organic group.
B01J 31/04 - Catalyseurs contenant des hydrures, des complexes de coordination ou des composés organiques contenant des composés organiques ou des hydrures métalliques contenant des acides carboxyliques ou leurs sels
The present invention provides: an asymmetric hydrogenation catalyst comprising a heteropoly acid, a solid-phase support containing a basic group and a platinum-group complex; and a method for producing an optically active amide compound, comprising a step for asymmetrically hydrogenating an enamide compound in the presence of the asymmetric hydrogenation catalyst to produce an optically active amide compound.
B01J 31/34 - Catalyseurs contenant des hydrures, des complexes de coordination ou des composés organiques contenant en outre des composés métalliques inorganiques non prévus dans les groupes du chrome, du molybdène ou du tungstène
C07C 231/12 - Préparation d'amides d'acides carboxyliques par des réactions n'impliquant pas la formation de groupes carboxamide
C07C 233/05 - Amides d'acides carboxyliques ayant des atomes de carbone de groupes carboxamide liés à des atomes d'hydrogène ou à des atomes de carbone acycliques ayant les atomes d'azote des groupes carboxamide liés à des atomes d'hydrogène ou à des atomes de carbone de radicaux hydrocarbonés non substitués avec des atomes de carbone de groupes carboxamide liés à des atomes de carbone d'un squelette carboné saturé acyclique ayant les atomes d'azote des groupes carboxamide liés à des atomes d'hydrogène ou à des atomes de carbone acycliques
61.
ANTI-INFLAMMATORY AGENT AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES HAVING ANTI-INFLAMMATORY ACTION
The present invention addresses the problem of providing a therapeutic agent, especially an anti-inflammatory agent, that is constituted by a mass of extracellular vesicles having highly therapeutic effects. The present invention relates to an anti-inflammatory agent containing, as an active ingredient, extracellular vesicles obtained from extracellular vesicles originating from mesenchymal stem cells via a method utilizing a substance having an affinity for phosphatidylserine; as well as a method for producing extracellular vesicles having anti-inflammatory action, the method including obtaining extracellular vesicles from extracellular vesicles originating from mesenchymal stem cells via a method utilizing a substance having an affinity for phosphatidylserine.
A61K 35/28 - Moelle osseuseCellules souches hématopoïétiquesCellules souches mésenchymateuses de toutes origines, p. ex. cellules souches dérivées de tissu adipeux
A61K 35/30 - NerfsCerveauYeuxCellules cornéennesLiquide céphalorachidienCellules souches neuronalesCellules précurseurs neuronalesCellules glialesOligodendrocytesCellules de SchwannAstrogliesAstrocytesPlexus choroïdeTissu de moelle épinière
A61K 35/51 - Cordon ombilicalSang de cordon ombilicalCellules souches ombilicales
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
The present invention addresses the problem of providing a therapeutic preparation, especially an antifibrotic agent, that is configured from a population of extracellular vesicles having a high therapeutic effect. The present invention pertains to: an antifibrotic agent having extracellular vesicles derived from mesenchymal stem cells as an active ingredient, wherein the extracellular vesicles are obtained by a method that utilizes a substance having an affinity for phosphatidyl serine and/or are derived from mesenchymal stem cells of which the extracellular vesicles have been stimulated by a fibroblast growth factor; and a method for producing extracellular vesicles as such an antifibrotic agent.
A61K 35/28 - Moelle osseuseCellules souches hématopoïétiquesCellules souches mésenchymateuses de toutes origines, p. ex. cellules souches dérivées de tissu adipeux
A61K 35/30 - NerfsCerveauYeuxCellules cornéennesLiquide céphalorachidienCellules souches neuronalesCellules précurseurs neuronalesCellules glialesOligodendrocytesCellules de SchwannAstrogliesAstrocytesPlexus choroïdeTissu de moelle épinière
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
The present invention addresses the issue of providing a therapeutic formulation, in particular an angiogenic agent, comprising a group of extracellular vesicles having a high therapeutic effect. The present invention pertains to: an angiogenic agent that has extracellular vesicles derived from mesenchymal stem cells as an effective component thereof and is obtained by a method that uses a substance having extracellular vesicles that have affinity with phosphatidylserine and/or is an angiogenic agent derived from mesenchymal stem cells having extracellular vesicles that have been stimulated by growth factors; and a production method for extracellular vesicles as an angiogenic agent.
A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées
A61K 35/28 - Moelle osseuseCellules souches hématopoïétiquesCellules souches mésenchymateuses de toutes origines, p. ex. cellules souches dérivées de tissu adipeux
A61K 35/30 - NerfsCerveauYeuxCellules cornéennesLiquide céphalorachidienCellules souches neuronalesCellules précurseurs neuronalesCellules glialesOligodendrocytesCellules de SchwannAstrogliesAstrocytesPlexus choroïdeTissu de moelle épinière
TOKYO METROPOLITAN GERIATRIC HOSPITAL AND INSTITUTE OF GERONTOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (Japon)
Inventeur(s)
Kawakami Kyojiro
Fujita Yasunori
Ito Masafumi
Mizutani Kosuke
Ishikawa Tomokazu
Abrégé
The present invention addresses the problem of providing a novel prostate cancer marker that can be used to easily and specifically diagnose metastatic castration-resistant prostate cancer, and that monitors the progression of metastatic castration-resistant prostate cancer. The present invention pertains to a "method for assisting the diagnosis of metastatic castration-resistant prostate cancer, the method including measuring an amount of extracellular vesicles having a prostate-specific membrane antigen and phosphatidylserine in a biological sample derived from a test subject, and using the amount of extracellular vesicles, having the prostate-specific membrane antigen and phosphatidylserine, as an indicator to determine that the test subject has metastatic castration-resistant prostate cancer."
G01N 33/53 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
65.
PRIMER SET FOR DETECTING MYCOBACTERIUM TUBERCULOSIS, MYCOBACTERIUM AVIUM, AND MYCOBACTERIUM INTRACELLULARE AND METHOD USING SAME, AND REAGENT KIT THEREFOR
The present invention addresses the problem of providing a method enabling detection of bacteria belonging to the genus Mycobacterium existing in a sample even when there is a difference in concentration (number of copies) between the bacteria. The present invention pertains to a primary set comprising (i) a primer pair that is for detecting Mycobacterium tuberculosis and that is a combination of a forward primer having the base sequence represented by SEQ ID NO: 1 and a reverse primer having the base sequence represented by SEQ ID NO: 2, (ii) a primer pair that is for detecting Mycobacterium avium and is a combination of a forward primer having the base sequence represented by SEQ ID NO: 3 and a reverse primer having the base sequence represented by SEQ ID NO: 4, and (iii) a primer pair that is for detecting Mycobacterium intracellulare and is a combination of a forward primer having the base sequence represented by SEQ ID NO: 5 and a reverse primer having the base sequence represented by SEQ ID NO: 6.
C12Q 1/686 - Réaction en chaine par polymérase [PCR]
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
G01N 33/53 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet
G01N 33/536 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet avec formation d'un complexe immunologique en phase liquide
G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
66.
HORSESHOE CRAB-DERIVED RECOMBINANT Factor G AND METHOD FOR MEASURING β-GLUCAN USING SAME
The present invention addresses the problems of providing a horseshoe crab-derived factor G that exhibits a β-glucan-dependent activation and providing, using same, a highly sensitive method for measuring β-glucan. The present invention relates to "a heterodimer that combines a factor G α-subunit containing an amino acid sequence that is the same as or substantially the same as the amino acid sequence given by SEQ ID NO: 2 or SEQ ID NO: 4, with a factor G β-subunit containing an amino acid sequence that is the same as or substantially the same as the amino acid sequence given by any one of SEQ ID NOs: 6, 8, 10, 12, 14, or 16; a method for measuring β-glucan using said heterodimer; and a β-glucan measurement kit comprising said heterodimer".
C12N 15/12 - Gènes codant pour des protéines animales
C12N 15/57 - Hydrolases (3) agissant sur les liaisons peptidiques (3.4)
C12Q 1/37 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir une hydrolase faisant intervenir une peptidase ou une protéinase
C12N 9/64 - Protéinases provenant de tissu animal, p. ex. rennine
67.
METHOD FOR ASSISTING WITH DIAGNOSIS OF ALZHEIMER'S DISEASE OR MILD COGNITIVE IMPAIRMENT, BIOMARKER, REAGENT KIT, AND DEVICE
The present invention addresses the problem of providing a method for easily assisting with the diagnosis of Alzheimer's disease or mild cognitive impairment, a biomarker, a reagent kit, and a device. The present invention relates to a method for assisting with the diagnosis of Alzheimer's disease, said method including using an amount of phosphatidylserine- and tetraspanin-containing extracellular vesicles as an index to determine whether a subject has Alzheimer's disease. The present invention also relates to a method for assisting with the diagnosis of Alzheimer's disease or mild cognitive impairment, said method including using a ratio of the amount of phosphatidylserine- and tetraspanin-containing extracellular vesicles to the amount of tetraspanin-containing extracellular vesicles as an index to determine whether a subject has Alzheimer's disease or mild cognitive impairment. The present invention further relates to a biomarker, a reagent kit, and a device.
G01N 33/92 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des lipides, p. ex. le cholestérol
68.
METHOD FOR ASSISTING DIAGNOSIS OF PARKINSON'S DISEASE, BIOMARKER, REAGENT KIT, AND DEVICE
The present invention addresses the problem of providing: a method for assisting the diagnosis of Parkinson's disease in a simple manner; a biomarker; a reagent kit; and a device. The present invention relates to: a method for assisting the diagnosis of Parkinson's disease, the method comprising measuring the amount of an extracellular vesicle having phosphatidylserine and tetraspanin or both of the amount of an extracellular vesicle having phosphatidylserine and tetraspanin and the amount of an extracellular vesicle having tetraspanin and determining that a subject is affected by Parkinson's disease by employing, as a measure, the amount of the extracellular vesicle having phosphatidylserine and tetraspanin or the ratio of the amount of the extracellular vesicle having phosphatidylserine and tetraspanin to the amount of the extracellular vesicle having tetraspanin; a biomarker; a reagent kit; and a device.
G01N 33/92 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des lipides, p. ex. le cholestérol
C12M 1/34 - Mesure ou test par des moyens de mesure ou de détection des conditions du milieu, p. ex. par des compteurs de colonies
G01N 33/53 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
69.
METHOD, KIT, AND BIOMARKER FOR ASSISTING IN DIAGNOSIS OF COLON CANCER
PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY (Japon)
Inventeur(s)
Kawasaki Nana
Ohta Yuki
Abrégé
The present invention addresses the problem of providing a biomarker that makes it possible to diagnose colon cancer. The present invention relates to a biomarker that is for assisting in the diagnosis of colon cancer and that contains a sugar chain selected from among the following substances (1)-(4): (1) at least one sugar chain that is present in alpha 1-antitrypsin and represented by formula 1 or 2; (2) a sugar chain that is present in leucine-rich alpha-2 glycoprotein and represented by formula 1; (3) at least one sugar chain that is present in alpha 1-antichymotrypsin and represented by formula 1 or 2; and (4) a sugar chain that is present in complement component 9 and represented by formula 1.
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
C12N 15/12 - Gènes codant pour des protéines animales
C12N 15/15 - Inhibiteurs de protéases, p. ex. antithrombine, antitrypsine, hirudine
C12Q 1/02 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des micro-organismes viables
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
The present invention addresses the problem of providing a phosphoramidite activator which improves the solubility of 5-benzylthio-1H-tetrazole in acetonitrile without lowering the yield and purity of a target product. The present invention relates to: a phosphoramidite activator which contains (i) at least one compound that is selected from the group consisting of piperidine, pyrrolidine, N-alkyl piperidine and N-alkyl pyrrolidine, (ii) 5-benzylthio-1H-tetrazole and (iii) acetonitrile; and a method for activating phosphoramidite and a method for synthesizing a phosphoric acid ester or a thiophosphoric acid ester, said methods using the above-described activator.
The present invention addresses the problem of providing a primer pair for detecting Pneumocystis jirovecii, said primer pair resulting in false negative cases at a low possibility and having a high sensitivity, a method for detecting Pneumocystis jirovecii using the primer pair, and a reagent kit therefor. The present invention pertains to "a primer pair for detecting Pneumocystis jirovecii that is selected from the group consisting of: (i) a combination of a forward primer comprising the base sequence represented by SEQ ID NO:1 with a reverse primer comprising the base sequence represented by SEQ ID NO:2; (ii) a combination of a forward primer comprising the base sequence represented by SEQ ID NO:1 with a reverse primer comprising the base sequence represented by SEQ ID NO:4; and (iii) a combination of a forward primer comprising the base sequence represented by SEQ ID NO:3 with a reverse primer comprising the base sequence represented by SEQ ID NO:2".
C12Q 1/00 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions
C12Q 1/6895 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les plantes, les champignons ou les algues
C12N 9/00 - Enzymes, p. ex. ligases (6.)ProenzymesCompositions les contenantProcédés pour préparer, activer, inhiber, séparer ou purifier des enzymes
G01N 33/53 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet
G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
72.
BINDER FOR ELECTRICITY STORAGE DEVICES IMPROVING DISPERSIBILITY OF CONDUCTIVE ASSISTANT
The present invention addresses the problem of providing: a binder which exhibits excellent dispersibility of a conductive assistant; a slurry composition and an electrode, each of which uses this binder; and an electricity storage device which is provided with this electrode. The present invention relates to: a binder for electricity storage devices, wherein the loss tangent tanδ in the linear region of an aqueous dispersion that contains 0.5% by mass of the binder and 4.6% by mass of a conductive assistant satisfies tanδ > 1 as determined by a strain dispersion measurement at a measurement temperature of 25°C and a frequency of 1 Hz, provided that the conductive assistant is an acetylene black having an average particle diameter of from 30 nm to 40 nm and a specific surface area of from 65 m2/g to 70 m2/g; a slurry composition and an electrode, each of which uses this binder; an electricity storage device which is provided with this electrode; and the like.
C08F 220/00 - Copolymères de composés contenant un ou plusieurs radicaux aliphatiques non saturés, chaque radical ne contenant qu'une seule liaison double carbone-carbone et un seul étant terminé par un seul radical carboxyle ou un sel, anhydride, ester, amide, imide ou nitrile
C08F 236/00 - Copolymères de composés contenant plusieurs radicaux aliphatiques non saturés et l'un au moins contenant plusieurs liaisons doubles carbone-carbone
The present invention addresses the problem of providing: a binder which is capable of imparting an electrode with excellent flexibility; a slurry composition and an electrode, each of which uses this binder; and an electricity storage device which is provided with this electrode. The present invention relates to: a binder for electricity storage devices, said binder containing a salt of a polymer which contains structural units derived from (i) an ethylenically unsaturated carboxylic acid monomer and (ii) an ethylenically unsaturated monomer having at least one group selected from among a hydroxy group, a dialkylamino group, an acetyl group, a sulfo group, a phosphoric acid group and a cyano group, and which is neutralized by a monoamine, a polyvalent amine having an amine value of less than 21 and/or an onium hydroxide; a slurry composition and an electrode, each of which uses this binder; an electricity storage device which is provided with this electrode; and the like.
C08F 220/00 - Copolymères de composés contenant un ou plusieurs radicaux aliphatiques non saturés, chaque radical ne contenant qu'une seule liaison double carbone-carbone et un seul étant terminé par un seul radical carboxyle ou un sel, anhydride, ester, amide, imide ou nitrile
C08F 236/00 - Copolymères de composés contenant plusieurs radicaux aliphatiques non saturés et l'un au moins contenant plusieurs liaisons doubles carbone-carbone
The present invention addresses the problem of providing a method for judging inflammatory bowel disease that comprises a simple measurement procedure and correctly reflects clinical conditions. The present invention pertains to "an anti-human haptoglobin antibody that binds specifically to a region having the amino acid sequence represented by SEQ ID NO:1 in the α-chain of human haptoglobin, a method for judging inflammatory bowel disease with the use of the antibody, and a kit that contains the antibody and is for quantifying human haptoglobin to judge inflammatory bowel disease".
222S; a negative electrode that contains magnesium metal or a magnesium alloy; and an electrolyte solution that is obtained by mixing a compound represented by general formula (I) or the like, a Lewis acid or the like, and a solvent. (In general formula (I), each of X1and X2independently represents a chlorine atom or a bromine atom; and R122222 group, a halogeno group, an alkyl group, an alkoxy group, a vinyl group, a phenyl group or a phenoxy group.)
H01M 4/46 - Alliages à base de magnésium ou d'aluminium
H01M 4/54 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs d'oxydes ou d'hydroxydes inorganiques d'argent
H01M 4/58 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs de composés inorganiques autres que les oxydes ou les hydroxydes, p. ex. sulfures, séléniures, tellurures, halogénures ou LiCoFyEmploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs de structures polyanioniques, p. ex. phosphates, silicates ou borates
H01M 10/054 - Accumulateurs à insertion ou intercalation de métaux autres que le lithium, p. ex. au magnésium ou à l'aluminium
H01M 10/0567 - Matériaux liquides caracterisés par les additifs
H01M 10/0568 - Matériaux liquides caracterisés par les solutés
76.
STORAGE STABILIZER FOR EXTRACELLULAR VESICLE AND STORAGE STABILIZATION METHOD FOR EXTRACELLULAR VESICLE
The present invention addresses the problem of providing a means capable of stably storing an extracellular vesicle. The present invention pertains to: a storage stabilizer which is for an extracellular vesicle and contains a copolymer having a monomer unit derived from vinyl pyrrolidone and a monomer unit derived from vinyl acetate, or a polymer having a monomer unit derived from vinyl pyrrolidone such as polyvinyl pyrrolidone; and a storage stabilization method which is for an extracellular vesicle and includes cryopreserving an extracellular vesicle in the presence of the polymer.
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
An object of the present invention is to provide an excellent binder agent composition solving problems such as the decrease in a charge/discharge capacity that occurs in a case where a silicon-containing active material is used, a slurry composition and an electrode in which the binder agent composition is used, and a method for preparing the electrode. The present invention relates to “a binder agent composition containing (A) one or more kinds of polymers containing polyacrylic acid, (B) a bivalent to decavalent alcohol, and (C) water”, “a slurry composition for lithium batteries, containing 1) a silicon-containing active material, 2) a conductive assistant, and 3) the binder agent composition”, “an electrode for lithium batteries that has 1) a silicon-containing active material, 2) a conductive assistant, 3) a binder agent derived from the binder agent composition, and 4) a current collector”, and “a method for preparing an electrode for lithium batteries, including coating a current collector with the slurry composition and drying the slurry composition after the coating”.
H01M 10/0525 - Batteries du type "rocking chair" ou "fauteuil à bascule", p. ex. batteries à insertion ou intercalation de lithium dans les deux électrodesBatteries à l'ion lithium
The purpose of the present invention is to provide a highly practical electrolyte solution which has high oxidation resistance and which enables the repeated dissolution/precipitation of magnesium to proceed stably. The present invention relates to: an electrolyte solution for a magnesium cell, obtained by mixing a compound represented by general formula [1], a Lewis acid or a compound represented by general formula [4], and a solvent; an electrochemical device including the electrolyte solution; and a compound represented by general formula [1]. [In general formula [1], X1represents a halogeno group, and R133MgX2(X233MgX2(X233MgX2(X233MgX2(X2being the same as above).] (In general formula [4], the four R4s each independently represent a C1-6 alkyl group, a C1-6 perfluoroalkyl group, a phenyl group, or a perfluorophenyl group.)
C07C 309/04 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant un seul groupe sulfo
C07C 309/05 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant au moins deux groupes sulfo liés au squelette carboné
C07C 309/06 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant des atomes d'halogène ou des groupes nitro ou nitroso liés au squelette carboné
C07C 309/29 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone de cycles aromatiques à six chaînons d'un squelette carboné de cycles aromatiques à six chaînons non condensés
An object of the present invention is to provide a light- or heat-curing method by which a cured product (crosslinked product or resin) can be prepared in a simple method even in a case where filler is contained in a large amount; a curable resin composition which is used in the curing method; and the like.
The present invention provides a light- or heat-curing method containing a step 1 of obtaining (E) a condensate having constitutional units of Si—O—Al and/or Si—O—Si, obtained from aluminum derived from an aluminum alkoxide and a silane derived from a silane coupling agent having a mercapto group, from (A) a compound that is formed of a salt of a carboxylic acid and an amine and has a carbonyl group generating a radical and a carboxylate group generating a base through decarboxylation by irradiation with light or heating, the (B) aluminum alkoxide, the (C) silane coupling agent having a mercapto group, and (D) water, and a step 2 of performing a reaction among the (E) condensate, (H) a compound having two or more polymerizable unsaturated groups, and (I) filler under the conditions of irradiation with light or heating in the presence of the (A) compound; a curable resin composition which is used in the curing method; and the like.
C08G 75/045 - Polythioéthers à partir de composés mercapto ou de leurs dérivés métalliques à partir de composés mercapto et de composés insaturés
C08G 79/10 - Composés macromoléculaires obtenus par des réactions créant dans la chaîne principale de la macromolécule une liaison contenant des atomes autres que le silicium, le soufre, l'azote, l'oxygène et le carbone, avec ou sans ces derniers éléments créant une liaison contenant de l'aluminium
C08L 85/00 - Compositions contenant des composés macromoléculaires obtenus par des réactions créant dans la chaîne principale de la macromolécule une liaison contenant des atomes autres que le silicium, le soufre, l'azote, l'oxygène et le carboneCompositions contenant des dérivés de tels polymères
C09D 185/00 - Compositions de revêtement à base de composés macromoléculaires obtenus par des réactions créant dans la chaîne principale de la macromolécule une liaison contenant des atomes autres que le silicium, le soufre, l'azote, l'oxygène et le carboneCompositions de revêtement à base de dérivés de tels polymères
C09K 5/14 - Substances solides, p. ex. pulvérulentes ou granuleuses
H01M 4/58 - Emploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs de composés inorganiques autres que les oxydes ou les hydroxydes, p. ex. sulfures, séléniures, tellurures, halogénures ou LiCoFyEmploi de substances spécifiées comme matériaux actifs, masses actives, liquides actifs de structures polyanioniques, p. ex. phosphates, silicates ou borates
H01G 11/30 - Électrodes caractérisées par leur matériau
H01G 11/62 - Électrolytes liquides caractérisés par le soluté, p. ex. sels, anions ou cations
H01M 4/136 - Électrodes à base de composés inorganiques autres que les oxydes ou les hydroxydes, p. ex. sulfures, séléniures, tellurures, halogénures ou LiCoFy
H01M 4/1397 - Procédés de fabrication d’électrodes à base de composés inorganiques autres que les oxydes ou les hydroxydes, p. ex. sulfures, séléniures, tellurures, halogénures ou LiCoFy
H01M 4/62 - Emploi de substances spécifiées inactives comme ingrédients pour les masses actives, p. ex. liants, charges
H01M 6/16 - Éléments avec électrolytes non aqueux avec électrolyte organique
H01M 10/054 - Accumulateurs à insertion ou intercalation de métaux autres que le lithium, p. ex. au magnésium ou à l'aluminium
H01M 10/0568 - Matériaux liquides caracterisés par les solutés
H01M 12/08 - Éléments hybridesLeur fabrication composés d'un demi-élément du type élément à combustible et d'un demi-élément du type à élément secondaire
81.
REAGENT STORAGE APPARATUS, REAGENT STORAGE METHOD, AND SHUTTER
Compared to when the opening of a reagent case is always open, this reagent storage apparatus enables maintaining for a long period of time the performance of a reagent in a reagent container that is unsealed and housed in a reagent case. This reagent storage apparatus, which is a reagent case 2 housing a reagent container, includes: a shutter which opens and closes an opening in the reagent case, which is provided with an opening for inserting and removing a probe that sucks the reagent in the housed reagent container; and a movement mechanism which, after the shutter has been moved to an upper position away from the opening and opposite of the opening, closes the opening by moving the shutter downwards, and, after opening the opening by moving the shutter closing the opening upwards, retracts the shutter from the upper position above the opening.
G01N 35/00 - Analyse automatique non limitée à des procédés ou à des matériaux spécifiés dans un seul des groupes Manipulation de matériaux à cet effet
G01N 35/02 - Analyse automatique non limitée à des procédés ou à des matériaux spécifiés dans un seul des groupes Manipulation de matériaux à cet effet en utilisant une série de récipients à échantillons déplacés par un transporteur passant devant un ou plusieurs postes de traitement ou d'analyse
A read/write device 20 for a read/write system 1 wherein: radio waves are emitted from the read/write device 20 to an array of electronic tags 10, while at least either the array of electronic tags 10 formed having a plurality of electronic tags 10 lined up in a prescribed direction or the read/write device 20 which reads and writes sequential information to/from the plurality of tags is moved relative to the other; and information is read/written to/from the electronic tags 10. The read/write device 20 includes: an antenna substrate 22 comprising an antenna that emits radio waves and having a radio wave emission surface 23 that emits radio waves and is arranged inclined from a posture facing the electronic tags 10; and a radio wave absorbing body 24 arranged on the radio wave emission side of the antenna substrate 22 and narrowing the emission area W for radio waves emitted from the radio wave emission surface 23, narrowing same in the direction of the array of electronic tags 10.
G06K 7/10 - Méthodes ou dispositions pour la lecture de supports d'enregistrement par radiation électromagnétique, p. ex. lecture optiqueMéthodes ou dispositions pour la lecture de supports d'enregistrement par radiation corpusculaire
G01N 35/02 - Analyse automatique non limitée à des procédés ou à des matériaux spécifiés dans un seul des groupes Manipulation de matériaux à cet effet en utilisant une série de récipients à échantillons déplacés par un transporteur passant devant un ou plusieurs postes de traitement ou d'analyse
PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY (Japon)
Inventeur(s)
Kawasaki Nana
Ohta Yuki
Ichikawa Yasushi
Terauchi Yasuo
Shibata Wataru
Abrégé
The present invention addresses the problem of providing a pancreatic cancer determination marker having a high accuracy (correctness and precision). The present invention pertains to a pancreatic cancer determination marker, a pancreatic cancer determination method, a method for acquiring data for determining a pancreatic cancer, a pancreatic cancer determination kit, and the like.
G01N 33/574 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour le cancer
G01N 33/66 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir les sucres du sang, p. ex. le galactose
The present invention addresses the problem of providing a novel determination method that can determine prostate carcinoma at a higher biopsy avoidance rate. The present invention relates to "a method for determining prostate carcinoma, by obtaining a ratio 1 between the amount of free prostate specific antigen in a sample from a subject and the amount of α(2,3)-sugar chain free PSA which is free prostate specific antigen having a sugar chain in which a terminal sialic acid residue of the sugar chain is α(2,3)-linked to the second galactose residue from the end of the sugar chain; obtaining a ratio 2 between the ratio 1 and the volume of the prostate in the subject; and determining prostate carcinoma based on the obtained ratio 2.".
The present invention relates to an electrolytic solution for a magnesium battery, formed by mixing a compound represented by the following general formula (I), a Lewis acid or a compound represented by the following general formula (A), and a solvent; and the like.
1's may also form the following general formula (2).}
10's each independently represent an alkyl group, a perfluoroalkyl group, a phenyl group, or a perfluorophenyl group.)
The present invention addresses the problem of providing a highly exact (accurate and precise) method for judging a psychiatric disorder such as depressive disorder, bipolar disorder, schizophrenia or dementia. The present invention pertains to a method for judging a psychiatric disorder, a marker for judging a psychiatric disorder, etc.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
87.
METHOD FOR PURIFYING TARGET REGION, DETECTION METHOD, AND METHOD FOR DETERMINING CANCER
The problem addressed by the present invention is to provide a method capable of purifying a target region simply, accurately, and in a short time. The present invention relates to a "method for purifying a target region in double-stranded DNA and a detection method, and a method for determining cancer."
C12N 15/10 - Procédés pour l'isolement, la préparation ou la purification d'ADN ou d'ARN
C12N 15/11 - Fragments d'ADN ou d'ARNLeurs formes modifiées
C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques
C12Q 1/686 - Réaction en chaine par polymérase [PCR]
Quenchers of the related art do not have a quenching ability high enough to sufficiently inhibit the emission of fluorescence from fluorescence compounds. Therefore, the present invention aims to provide a quencher which can sufficiently quench the fluorescence from fluorescent compounds including xanthene-based dyes. The present invention relates to a quencher formed of a compound represented by the following general formula (1), and the like.
33 each independently represent an alkyl group or an aryl group.).
C07F 7/10 - Composés comportant une ou plusieurs liaisons C—Si azotés
C08F 230/08 - Copolymères de composés contenant un ou plusieurs radicaux aliphatiques non saturés, chaque radical ne contenant qu'une seule liaison double carbone-carbone et contenant du phosphore, du sélénium, du tellure ou un métal contenant un métal contenant du silicium
C08F 30/08 - Homopolymères ou copolymères de composés contenant un ou plusieurs radicaux aliphatiques non saturés, chaque radical ne contenant qu'une seule liaison double carbone-carbone et contenant du phosphore, du sélénium, du tellure ou un métal contenant un métal contenant du silicium
12101011 represents: an alkylene group having at least one group selected from -OCO-, -COO-, -NHCONH-, etc. in the chain and/or at the end; an alkylene group having at least one group selected from -OCO-, -COO-, -NHCONH-, etc. in the chain and/or at the end, and having a hydroxy group as a substituent; an alkylene group having a hydroxy group as a substituent; or an alkylene group).
C09D 17/00 - Pigments en pâtes, p. ex. pour pigmenter les peintures
B41J 2/01 - Machines à écrire ou mécanismes d'impression sélective caractérisés par le procédé d'impression ou de marquage pour lequel ils sont conçus caractérisés par la mise en contact sélective d'un liquide ou de particules avec un matériau d'impression à jet d'encre
B41M 5/00 - Procédés de reproduction ou méthodes de reproduction ou de marquageMatériaux en feuilles utilisés à cet effet
C08J 3/03 - Production de solutions, dispersions, latex ou gel par d'autres procédés que ceux utilisant les techniques de polymérisation en solution, en émulsion ou en suspension dans un milieux aqueux
6's each independently represent an alkyl group having 1 to 6 carbon atoms, a perfluoroalkyl group having 1 to 6 carbon atoms, a phenyl group, or a perfluorophenyl group.
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques
C12Q 1/6853 - Réactions d’amplification d’acides nucléiques utilisant des amorces ou des matrices modifiées
An object of the present invention is to provide a copolymer which is capable of forming a viscous aqueous solution having a desired viscosity in the presence of an electrolyte, in particular, a polyvalent electrolyte, a thickening agent comprising the copolymer, and a cosmetic preparation comprising the copolymer. The present invention relates to an acrylic acid ester (A)/compound (B) copolymer, comprising, as constitutional components, an acrylic acid ester (A) and a compound (B), wherein the acrylic acid ester (A) is represented by the general formula [1], and the compound (B) has, in each molecule, a polymerizable unsaturated group and any functional group selected from the group consisting of a carboxyl group, a sulfo group, and a phosphate group, and a weight ratio of the acrylic acid ester (A) and the compound (B), which is (A)/(B), is 9.0/91.0 to 28.5/71.5; a thickening agent comprising the copolymer; and a cosmetic preparation comprising the copolymer;
General Formula [1]:
1 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and m represents an integer of 2 to 4.
A61K 8/81 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons insaturées carbone-carbone
A61Q 19/00 - Préparations pour les soins de la peau
C08F 220/26 - Esters contenant de l'oxygène en plus de l'oxygène de la fonction carboxyle
C08F 230/02 - Copolymères de composés contenant un ou plusieurs radicaux aliphatiques non saturés, chaque radical ne contenant qu'une seule liaison double carbone-carbone et contenant du phosphore, du sélénium, du tellure ou un métal contenant du phosphore
A61K 8/55 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant du phosphore
A61Q 1/02 - Préparations contenant des colorants cutanés, p. ex. pigments
A61Q 1/10 - Préparations contenant des colorants cutanés, p. ex. pigments pour les yeux, p. ex. eye-liner, mascara
A61Q 5/02 - Préparations pour le lavage des cheveux
A61Q 5/04 - Préparations pour onduler de façon permanente ou décrêper les cheveux
A61Q 5/06 - Préparations pour mettre les cheveux en forme, p. ex. pour mettre en forme ou colorer temporairement
A61Q 5/10 - Préparations pour la teinture permanente des cheveux ou des poils
A61Q 15/00 - Préparations contre la transpiration ou déodorants corporels
A61Q 17/04 - Préparations topiques pour faire écran au soleil ou aux radiationsPréparations topiques pour bronzer
A61Q 19/10 - Préparations pour le nettoyage ou le bain
C08F 220/06 - Acide acryliqueAcide méthacryliqueLeurs sels métalliques ou leurs sels d'ammonium
An object of the present invention is to provide a photocuring method, which makes it possible to rapidly and efficiently obtain a crosslinked product (resin), a compound used in the photocuring method, and a photocuring resin composition containing the compound.
The present invention relates to a photocuring method, which comprises a step 1 and a step 2 performed after the step 1, a compound used in the photocuring method, and a photocuring resin composition containing the compound.
Step 1: this is a step in which in the presence of (A) compound having a carbonyl group generating a radical by photoirradiation and a carboxyl group decarboxylated by photoirradiation, (B) silane coupling agent having a mercapto group or a (meth)acryl group is reacted with (C) water under acidic conditions to obtain (D) silane compound having a mercapto group or a (meth)acryl group and at least one silanol group.
Step 2: this is a step in which in the presence of the compound (A) and (E) compound having a carbonyl group generating a radical by photoirradiation and a group generating a base by being decarboxylated by photoirradiation, the compound (A) and the compound (E) are irradiated with light to create alkaline conditions in a reaction system by decarboxylating the carboxyl group of the compound (A) and generating a base from the compound (E), and radicals are generated from the compound (A) and the compound (E) to generate a crosslinked product containing a constitutional unit derived from the silane compound (D) from the silane compound (D) and, if necessary, from (F) compound having two or more polymerizable unsaturated groups.
C08F 2/46 - Polymérisation amorcée par énergie ondulatoire ou par rayonnement corpusculaire
C08F 2/50 - Polymérisation amorcée par énergie ondulatoire ou par rayonnement corpusculaire par la lumière ultraviolette ou visible avec des agents sensibilisants
C08G 61/04 - Composés macromoléculaires contenant uniquement des atomes de carbone dans la chaîne principale de la molécule, p. ex. polyxylylènes uniquement des atomes de carbone aliphatiques
C07D 335/16 - Atomes d'oxygène, p. ex. thioxanthones
C08G 75/045 - Polythioéthers à partir de composés mercapto ou de leurs dérivés métalliques à partir de composés mercapto et de composés insaturés
C07C 59/84 - Composés non saturés contenant des groupes cétone contenant des cycles aromatiques à six chaînons
C08F 299/08 - Composés macromoléculaires obtenus par des interréactions de polymères impliquant uniquement des réactions entre des liaisons non saturées carbone-carbone, en l'absence de monomères non macromoléculaires à partir de polycondensats non saturés à partir de polysiloxanes
C07C 279/26 - X et Y étant des atomes d'azote, c.-à-d. biguanides
C08G 77/20 - Polysiloxanes contenant du silicium lié à des groupes aliphatiques non saturés
C08G 77/28 - Polysiloxanes contenant du silicium lié à des groupes organiques contenant des atomes autres que le carbone, l'hydrogène et l'oxygène groupes contenant du soufre
The present invention relates to a compound represented by the general formula (A), a base- and/or radical-generating agent comprising the compound, and so on.
10 are each a hydrogen atom, and, in a case where two of the eight groups are each a hydrogen atom, then three to six of the remaining groups are each an alkyl group having 1 to 12 carbon atoms, and, in a case where three of the eight groups are each a hydrogen atom, then four or five of the remaining groups are each an alkyl group having 1 to 12 carbon atoms.
C07C 279/26 - X et Y étant des atomes d'azote, c.-à-d. biguanides
C07C 251/30 - Composés contenant des atomes d'azote, liés par des liaisons doubles à un squelette carboné contenant des groupes imino ayant des atomes d'azote de groupes imino quaternisés
C08G 59/40 - Macromolécules obtenues par polymérisation à partir de composés contenant plusieurs groupes époxyde par molécule en utilisant des agents de durcissement ou des catalyseurs qui réagissent avec les groupes époxyde caractérisées par les agents de durcissement utilisés
C08G 59/42 - Acides polycarboxyliquesLeurs anhydrides, halogénures ou esters à bas poids moléculaire
C08G 59/68 - Macromolécules obtenues par polymérisation à partir de composés contenant plusieurs groupes époxyde par molécule en utilisant des agents de durcissement ou des catalyseurs qui réagissent avec les groupes époxyde caractérisées par les catalyseurs utilisés
C08K 5/29 - Composés contenant des liaisons doubles carbone-azote
C08L 63/00 - Compositions contenant des résines époxyCompositions contenant des dérivés des résines époxy
C08L 101/00 - Compositions contenant des composés macromoléculaires non spécifiés
C08L 101/06 - Compositions contenant des composés macromoléculaires non spécifiés caractérisées par la présence de groupes déterminés contenant des atomes d'oxygène
The purpose of the present invention is to provide a light- or heat-curing method whereby a cured material (crosslinked material/resin) can be obtained even when a large amount of a filler is included, and to provide a curable resin composition used in the curing method. The present invention relates to a light- or heat-curing method and a curable resin composition used in the curing method, the curing method including: a step 1 for obtaining a condensate having Si-O-Al and/or Si-O-Si constituent units, obtained from a silane derived from a silane coupling agent having a mercapto group and aluminum derived from (E) an aluminum alkoxide, from (A) a compound comprising a salt of a carboxylic acid and an amine and having a carbonyl group for generating a radical and a carboxylate group for decarboxylating and generating a base by light irradiation or heating, (B) an aluminum alkoxide, (C) a silane coupling agent having a mercapto group, and (D) water; and a step 2 for reacting the condensate (E), (H) a compound having two or more polymerizable unsaturated groups, and (I) a filler under a condition of light irradiation or heating.
C08G 75/045 - Polythioéthers à partir de composés mercapto ou de leurs dérivés métalliques à partir de composés mercapto et de composés insaturés
C08G 79/10 - Composés macromoléculaires obtenus par des réactions créant dans la chaîne principale de la macromolécule une liaison contenant des atomes autres que le silicium, le soufre, l'azote, l'oxygène et le carbone, avec ou sans ces derniers éléments créant une liaison contenant de l'aluminium
C08L 85/00 - Compositions contenant des composés macromoléculaires obtenus par des réactions créant dans la chaîne principale de la macromolécule une liaison contenant des atomes autres que le silicium, le soufre, l'azote, l'oxygène et le carboneCompositions contenant des dérivés de tels polymères
C09D 185/00 - Compositions de revêtement à base de composés macromoléculaires obtenus par des réactions créant dans la chaîne principale de la macromolécule une liaison contenant des atomes autres que le silicium, le soufre, l'azote, l'oxygène et le carboneCompositions de revêtement à base de dérivés de tels polymères
C09K 5/14 - Substances solides, p. ex. pulvérulentes ou granuleuses
NATIONAL UNIVERSITY CORPORATION EHIME UNIVERSITY (Japon)
FUJIFILM WAKO PURE CHEMICAL CORPORATION (Japon)
Inventeur(s)
Kondoh, Masuo
Yagi, Kiyohito
Doi, Takefumi
Okada, Yoshiaki
Hashimoto, Yosuke
Sawasaki, Tatsuya
Takeda, Hiroyuki
Endo, Kohki
Tamura, Maki
Abrégé
The problem of providing a novel molecule having high specificity to CLDN-5 and capable of recognizing an extracellular domain of CLDN-5 can be solved by an antibody capable of specifically recognizing the three-dimensional structure or the primary structure of an extracellular domain of Claudin-5 protein.
C07K 16/28 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des récepteurs, des antigènes de surface cellulaire ou des déterminants de surface cellulaire
A61K 39/395 - AnticorpsImmunoglobulinesImmunsérum, p. ex. sérum antilymphocitaire
A61K 47/42 - ProtéinesPolypeptidesLeurs produits de dégradationLeurs dérivés p. ex. albumine, gélatine ou zéine
A61K 47/68 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un anticorps, une immunoglobuline ou son fragment, p. ex. un fragment Fc
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
The present invention addresses the problem of providing a method for increasing the amount of a complex of a substance having a sugar chain and a lectin. The present invention pertains to: a method for forming a complex of a substance having a sugar chain and a lectin, said method comprising contacting a sample containing the substance having the sugar chain with the lectin, which has compatibility with the sugar chain of the substance having the sugar chain, in the presence of an N-acetylglucosamine-free water-soluble polysaccharide or a water-soluble compound comprising an N-acetylglucosamine-free polysaccharide (the polysaccharide according to the present invention); and a promoter for the formation of a complex of a substance having a sugar chain and a lectin having compatibility with the sugar chain of the substance having the sugar chain, said promoter comprising the polysaccharide according to the present invention.
A method of producing an organic compound, which contains a step of performing a deodorization step using a flow reaction in a flow passage to remove, from a reaction liquid, a malodorous material generated or remaining in a reaction step,
wherein the organic compound is an industrially useful compound.
C07C 45/29 - Préparation de composés comportant des groupes C=O liés uniquement à des atomes de carbone ou d'hydrogènePréparation des chélates de ces composés par oxydation de groupes hydroxyle
C07C 315/00 - Préparation de sulfonesPréparation de sulfoxydes
C07C 317/04 - SulfonesSulfoxydes ayant des groupes sulfone ou sulfoxyde liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé
C07C 225/22 - Composés contenant des groupes amino et des atomes d'oxygène, liés par des liaisons doubles, liés au même squelette carboné, au moins un des atomes d'oxygène, liés par des liaisons doubles, ne faisant pas partie d'un groupe —CHO, p. ex. aminocétones ayant des groupes amino liés à des atomes de carbone de cycles aromatiques à six chaînons du squelette carboné
C07B 63/00 - PurificationSéparation spécialement adaptée aux fins d'isolement des composés organiquesStabilisationEmploi d'additifs
C07H 17/08 - Hétérocycles d'au moins huit chaînons, p. ex. érythromycines
C07C 221/00 - Préparation de composés contenant des groupes amino et des atomes d'oxygène, liés par des liaisons doubles, liés au même squelette carboné
C07C 223/06 - Composés contenant des groupes amino et —CHO liés au même squelette carboné ayant des groupes amino liés à des atomes de carbone de cycles aromatiques à six chaînons du squelette carboné
C07J 1/00 - Stéroïdes normaux contenant du carbone, de l'hydrogène, un halogène ou de l'oxygène, non substitués en position 17bêta par un atome de carbone, p. ex. œstrane, androstane
C07C 47/02 - Composés saturés comportant des groupes —CHO liés à des atomes de carbone acycliques ou à de l'hydrogène
C07C 47/228 - Composés non saturés comportant des groupes —CHO liés à des atomes de carbone acycliques contenant des cycles aromatiques à six chaînons, p. ex. le phénylacétaldéhyde
C07C 49/04 - Composés saturés comportant des groupes cétone liés à des atomes de carbone acycliques
C07C 49/403 - Composés saturés comportant un groupe cétone faisant partie d'un cycle d'un cycle à six chaînons
C07C 49/807 - Cétones comportant un groupe cétone lié à un cycle aromatique à six chaînons contenant des atomes d'halogène tous les atomes d'halogène étant liés au cycle
C07D 307/46 - Atomes d'oxygène liés par des liaisons doubles ou deux atomes d'oxygène liés par des liaisons simples au même atome de carbone
C07C 47/232 - Composés non saturés comportant des groupes —CHO liés à des atomes de carbone acycliques contenant des cycles aromatiques à six chaînons, p. ex. le phénylacétaldéhyde avec insaturation autre que celle des cycles aromatiques
C07C 49/303 - Composés saturés comportant des groupes cétone liés à des cycles à un cycle à six chaînons
C07C 49/76 - Cétones comportant un groupe cétone lié à un cycle aromatique à six chaînons
C07C 315/02 - Préparation de sulfonesPréparation de sulfoxydes par formation de groupes sulfone ou sulfoxyde par oxydation de sulfures ou par formation de groupes sulfone par oxydation de sulfoxydes
The purpose of the invention is to provide: an excellent binder agent composition that overcomes such problems as a reduction in charge/discharge capacity in cases of using a silicon-containing active material; a slurry composition and an electrode using said binder agent composition; and a method for preparing said electrode. This invention relates to: "a binder agent composition comprising (A) at least one type of polymer including a polyacrylic acid, (B) a bivalent to decavalent alcohol, and (C) water"; "a slurry composition for lithium batteries, comprising (1) a silicon-containing active material, (2) an electroconductive aid, and (3) said binder agent composition"; "an electrode for lithium batteries, comprising (1) a silicon-containing active material, (2) an electroconductive aid, (3) a binder agent derived from said binder agent composition, and (4) a charge collector"; and "a method for preparing an electrode for lithium batteries, characterized by applying said slurry composition on a charge collector, and then drying the same."
